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Abstract
The physical structure of cellular membranes plays a critical role in lipid and
protein sorting. A novel biosensor was developed to probe the influence of curvature on
sorting. This biosensor mimics large, two-dimensional membranes in dynamic
equilibrium, achieves high spatial resolution between curvature and molecules of interest,
and has high sensitivity, enough for single particle detection. The biosensor consists of
continuous supported lipid bilayer formed over nanoparticles (40 to 200 nm diameter)
deposited on a glass substrate. The nanoparticles determine the extent of curvature. This
biosensor is the first to observe large-scale 2-dimensional diffusion of biomolecules on a
supported lipid bilayer with small radii of curvature in equilibrium with flat areas of fluid
bilayer. This will allow correlation between protein function and the physical shape of a
membrane. Fluorescence microscopy was used to quantify spatial sorting of lipids and a
protein relevant to cardiovascular disease, C-reactive protein (CRP). Two lipids,
fluorescein labeled hexadecanoic acid and 1,2-dihexadecanoyl-sn-glycero-3phosphoethanolamine, sense curvature by accumulating in areas over nanoparticles, and
both are able to laterally exchange with surrounding lipids. Dynamic fluidity of the
bilayer was assessed using fluorescence recovery after photobleaching. Lipids directly at
sites of curvature recover more slowly than lipids over flat sections. The spatial
distribution of CRP was also assessed. Curvature sensing of CRP is isoform dependent
where native CRP does not sense curvature and modified CRP does sense curvature.
ii

Finally, we show that a ribonucleic acid aptamer will bind specifically to modified CRP
and not native CRP, enabling isoform specific studies of CRP to be conducted.
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Chapter One: Introduction
Membrane curvature plays an important role in several crucial cellular functions.
Changes to membrane curvature are found everywhere from cell birth to cell death. At
mitosis, the central section of the cell pinches in, dividing the cell in half. At cell death,
the plasma membrane loses stability, increases permeability, and ejects apoptotic bodies
into the intercellular space. These mechanisms in the cell are complex and layered with
confounding variables such as protein feedback loops, protein-lipid interplay, lipid
domain formation, and much more. The basic research presented here separates these
variables to gain fundamental insight into the processes at work. We investigate how
lipids and proteins sort with regard to membrane curvature. A novel biosensor was
developed that separates curvature generation from other chemical aspects of cellular
curvature, which enables us to probe the effects of curvature under controlled conditions.
This resulted in new information regarding the curvature sensing properties of various
lipids and a relevant cardiovascular marker, C-reactive protein.
Biological Relevance of Membrane Curvature
Membrane curvature is of particular interest in current biology (1,2,3,4,5,6,7,8,9).
Changes to curvature can be seen during apoptosis, endocytosis, mitosis/meiosis,
extracellular signaling, and many other cellular operations. However, other chemical and
physical changes occur during these operations, and often they are inseparable from
curvature changes. For example, during apoptosis several changes occur at the cellular
1

level. The plasma membrane in particular undergoes multiple changes including
increased permeability, changes to leaflet composition, oxidization of lipids, and the
formation of areas of high curvature (10). Fundamental understanding of cellular
processes relies on the ability to separate these variables and to categorize their individual
contributions to cellular activity. Techniques capable of separating these variables from
membrane curvature do exist, but each has its limitations. In this introduction, I will
establish the biological aspects of curvature and discuss model membrane systems that
mimic curvature found in a cell. These model systems served as the basis for our design
as we sought to minimize disadvantages and
maximize advantages in our system.
Given the varied macroscopic processes that
induce changes to curvature, it is not surprising to
find areas of extreme membrane curvature
throughout the cell interior. Curvature can be
transient, as in vesicle trafficking. It can also be in
more permanent structures like microvilli. Figure 1
is a graphic (2) that highlights the diversity of
curvature within a typical cell. The topology of a
Figure 1: Diagram detailing areas
in the cell where extreme
membrane curvature can occur.
Figure used with permission (2).

budding vesicle shows the different degrees of
curvature. Positive curvature creates a convex

surface of interaction and has a larger surface area than a corresponding flat membrane.
Negative curvature creates a concave surface of interaction with a smaller relative surface
area. Also note that if the bending surface is a bilayer, areas of both positive and
2

negative curvature are present, but on opposite leaflets. The terminology this work uses
is to identify curvature based on the surface of interaction. For example, a bilayer where
a protein binds to the convex surface would be
considered to have positive curvature, even
though a concave surface exists on the noninteracting face. A budding vesicle (Figure 2
(2)) is a good model process to consider for
membrane curvature since it transitions through
Figure 2: Schematic of a budding
vesicle shows varying extents of
curvature present during this process.
Figure used with permission (2)

various radii of curvature (ROC), demonstrates
both positive and negative curvature, and at one
point has a saddle which includes both positive

and negative curvature on the same interacting surface.
These changes to surface area are the main driver for the characteristic instability
of lipids in curvature. On the negative face, lipid head groups are forced together and
strong electrostatic forces repel the head groups from each other. The positive face
forces exposure of the hydrophobic tails to the aqueous solution creating entropic
instability. This lipid crowding on the negative face, and the corresponding hydrophobic
exposure on the positive face, cause instability in the curved structure. These
energetically unstable structures must be 1) maintained by proteins which stabilize the
strained morphology, or 2) accommodate a different leaflet ratio of lipids or different
types of lipids.
Apoptotic bodies and budding vesicles are ideal examples of membrane
curvature. Apoptosis is the process of programmed cell death and has several purposes in
3

the body, such as maintaining homeostasis and as an immune response (10). During this
process, the cells shrink in size, become more dense and irregular in shape. The plasma
membrane begins to bleb severely. These blebs later entirely release from the dying cell
as apoptotic bodies. The membranes of these bodies remain intact and are later absorbed
by surrounding macrophages or other cells where the contents of the bodies are recycled.
As a reference for size, endothelial cells create apoptotic bodies with radii of curvature
from 500 nm to 2 μm. Smaller ejections (microparticles) were also observed (11).
Comparatively, vesicle sizes are typically much smaller, with radii on the order of
10s to 100s of nanometers. This transport is the primary mechanism in cells to transfer
proteins between compartments of the endomembrane system and the plasma membrane,
and a primary mechanism for ingesting new material via endocytosis. Due to the large
extents of curvature, these vesicles are often accompanied by coat proteins which help
stabilize the unfavorable extreme curvature. Triggering of the vesicle formation usually
accompanies recruitment of cargo via receptor molecules. After reaching a destination,
these coat proteins detach, making the vesicle more fusogenic and easily incorporated
into the destination membrane (12,2).
Causes of Membrane Curvature
For a membrane to maintain a given structure in the face of this strained
morphology, lipid composition and protein coating change to counter and minimize the
energetic cost of bending. These two broad effects are not independent from each other,
but are discussed here separately for simplicity. A minor contribution to curvature comes
from the physical or molecular shape of the lipid (5). A typical saturated lipid like
phosphotidylcholine is cylindrical in shape, and this will stabilize zero curvature or a flat
4

membrane. As a flat membrane begins to curve, defects appear in the positive face (13).
A defect is a point in the membrane where the hydrophobic tails are exposed to aqueous
solvent, and this arises due to the increase in surface area of the positive face. These
defects are stabilized by inverse conical lipids, such as lysolipids or certain dye labeled
lipids. On the negative face of a curving membrane, head groups are forced closer
together due to the reduction in surface area. This steric hindrance is eased by conical
lipids like phosphatidic acid. The smaller head group and broader tail region help ease
the steric interaction between neighboring lipids. Differences in numbers of lipids
between the two leaflets also act to stabilize highly curved surfaces. In a liposome with
50 nm on the outer diameter and a thickness of 5 nm, the ratio of lipids on the outer
leaflet to inner leaflet is 1.23 (2). Lipids also tend to form domains that have bending
rigidity that hinder or assist in curvature formation. Cylindrical lipids tend to form
ordered domains with high bending
rigidity, whereas conical and inverted
conical lipids form disordered domains
with low rigidity. Though individual
lipids have a small contribution to
overall curvature formation, curvature
Figure 3: Crystal structure of a BAR dimer
with a proposed bilayer conforming to the
intrinsic shape. When a bilayer is fitted well to
the shape of the protein, more electrostatic
interactions are present, thus increasing
binding. Figure used with permission (2).

could influence the formation of
domains and further stabilize the
presence of domains (7). All of these

changes assist or hinder morphology directly, but certain lipids also act as sites for
protein binding, which can further influence curvature stability.
5

Proteins have several methods to influence
curvature. 1) Scaffolding is common in the cell and
functions by having a rigid protein structure conform
to and support a new membrane structure. Some
common examples of scaffolding proteins are clathrin,
the dynamin family, and caveolin (14,15,16,17). 2)
Many proteins incorporate BAR (Bin-AmphiphysinRvs) domains, dimer domains that have a distinctive
banana shape. These domains, seen in Figure 3 (2),
will sense curvature at low concentrations (18). When
the curvature of the membrane matches the intrinsic
curvature of the dimer, there is tighter binding. It is
Figure 4: Schematic of a bilayer
rearranging to accommodate an
inserted amphipathic helix. One
side of the helix is hydrophobic
while the other is positively
charged. Figure used with
permission (2).

expected that the binding energy of BAR domains to
curvature matches the energy required to bend the
membrane, as has been seen with amphiphysin (19).
3) Commonly operating alongside BAR domains are

amphipathic helices, in which the helix is attached to the N-terminus of the BAR domain
(the combination dubbed N-BAR). These protein domains will insert into a membrane
and increase the surface area and thus generate positive curvature. Figure 4 (2) shows the
wedge effect that generates the curvature. The α-helix structure has one face that is
hydrophobic and one face that is positively charged. The hydrophobic face inserts into
the tail section of the membrane while the positive face interacts with the head group
region (20). The one-sided insertion causes the surface area asymmetry. 4)
6

Microfilament (actin) and microtubule (tubulin) activity can deform the membrane
through changes in bilayer tension (21,22,23). It is interesting to note the complex
interplay that occurs between these mechanisms through tension. The cytoskeleton is
responsible for maintaining and changing tension, which causes a response in
microtubule activity, which affects both tension and feeds back to the cytoskeleton
activity (24). The cytoskeleton also plays a secondary role in morphology changes by
directing vesicles to sites of fusion and endocytosis. (25) 5) The final mechanism
responsible for membrane deformation is the presence of transmembrane proteins. These
proteins will typically prefer curvatures that mold around their shape. While this
mechanism is known to exist, such as with the voltage dependent K+-channel (26), not
much is broadly known about this effect since the structures of transmembrane proteins
remain elusive.
History of Fluorescence
The biosensor was designed with fluorescence microscopy in mind. This method
is extremely useful when studying biological systems, which we intend to mimic.
Fluorescence is a subcategory of luminescence, which is defined as “a spontaneous
emission of radiation from an electronically excited species (or from a vibrationally
excited species) not in thermal equilibrium with its environment.” (27). Fluorescence,
along with phosphorescence and delayed fluorescence, is a type of photoluminescence.
These forms of luminescence arise from excitation due to photon absorption and are
distinct from other excitation modes, like chemiluminescence and bioluminescence (27).
The first observation of fluorescence can be attributed to Spanish physician
Nicolás Monardes (28) in 1565. He reported a blue color from an infusion of Mexican
7

wood used to treat urinary diseases. This infusion was rare, thus making it a target of
counterfeiting. Dr. Monardes used the blue color as a method of detecting false infusions
(28). After Dr. Monardes, others noted similar color inconsistencies from natural
substances: 1) the dichroic nature of fluorite by Edward Clarke in 1819 (29), 2) again
fluorite by René-Just Haüy in 1822, who (incorrectly) identified the phenomenon as light
scattering (opalescence) (30), and 3) red color from chlorophyll extracts by Sir David
Brewster in 1833 (31). A major breakthrough in understanding fluorescence came in
1845 by Sir John Herschel. He was the first to note fluorescence from a single substance,
not a natural extract (32). Herschel used a prism to illuminate an acid solution of quinine
sulfate with blue light (33) to observe emitted light in the blue, green and yellow regions.
He failed to note that the emitted light was longer wavelength than the illumination light,
and thus attributed the phenomenon, like his predecessors, to scattered light. This crucial
observation would ultimately be made by George Stokes.
A turning point in understanding fluorescence, and coining of the term, came
from Sir George Gabriel Stokes in 1852. Stokes continued studying quinine solutions
and fluorite crystals, but he made the important observation that emitted light is always
longer wavelength than absorbed light (34). Using more sophisticated methods than
Herschel, Stokes used a prism to separate solar radiation and illuminated a solution of
quinine. In the visible region, nothing happened. When the tube was placed beyond the
violet region of the spectrum in the ‘invisible rays’ as Stokes describes it, the solution
glowed blue. He called it “…literally darkness visible.” (34) Though in his first work
Stokes continues the tradition of referring to the phenomenon as a derivative of scattering
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(in his work, he uses the term dispersive reflection), he admits in a footnote his dislike of
the term, and he coins the term fluorescence:
I confess I do not like this term. I am almost inclined to coin a word, and call the
appearance fluorescence, from fluorspar, as the analogous term opalescence is
derived from the name of a mineral. (34)
The red-shift that normally accompanies fluorescence is now known as the Stokes law or
Stokes shift in honor of Stokes’s contribution. It is useful to note that Edmond Becquerel
also observed a red shift of emitted light from calcium sulfide when illuminated with UV
light in 1842, 10 years earlier than Stokes (35,32). Becquerel even filed a priority claim
against Stokes (36,32) for this observation. However, a primary difference is that
Becquerel observed phosphorescence, not fluorescence, and Becquerel misinterpreted
Stokes’s observations as short-lived phosphorescence, disregarding the introduction of
Stokes’s ideas of the separate phenomenon fluorescence.
The next major advancement in understanding fluorescence came in the late 19th
century, along with other observations about the breakdown of classical mechanics and
the paradigm shift into quantum mechanics. Eilhard Wiedemann postulated scenarios
where the Second Law of Thermodynamics was violated. Fluorescence appeared to
allow energy to flow from cold objects to hotter objects (37,38). Additionally, several
physicists, including Franz Stenger in 1886 (39,32) and Ernest Merritt in 1904 (40), noted
observations where the Stokes law was violated and shorter wavelength fluorescence was
observed. A clue was noted by Lommel in 1878 who observed this apparent violation
only occurred when absorption and fluorescence curves overlap (41). Resolution to this
paradox finally came with Planck theory of quanta and Albert Einstein’s use of this
theory for luminescence. He proposed that the curves observed in fluorescence suggest a
9

statistical process, and that the violation of the Stokes law occurs because the molecular
vibration supplies the additional energy needed to blue shift emission. This would satisfy
both the First and Second Laws of Thermodynamics. Joseph von Kowalski later proved
this in 1910 by showing the violation of the Stokes law for rhodamine is larger at higher
temperatures, consistent with Einstein’s calculations (42).
Modern understanding of fluorescence is derived from the work of Francis Perrin
in 1922 (43) and Aleksander Jablonski in 1935 (44,45). Perrin introduced what is
commonly referred to now as the Jablonski diagram, which included a mechanism for the
Stokes shift and a metastable state. The metastable state was an attempt to describe longlived fluorescence and phosphorescence. However, Perrin did not include a path for
radiative transfer from this metastable state back to the ground state. Jablonski provided
this information to the diagram, thus cementing his namesake (45). The distinction
between fluorescence, a retention of spin multiplicity, and phosphorescence, a change in
spin multiplicity, was made by Terenin in 1943 and Kasha in 1944 (45).
Fluorescence has several uses in the modern scientific fields of chemistry,
physics, and medicine (45,46). Of particular note for this work is the application of
fluorescence recovery after photobleaching (FRAP) to microscopy of supported lipid
bilayers. Fluorescence microscopy was first used in 1942 by Coons, Creech, Jones and
Berliner to observe fluorescent antibody distribution in mouse tissue (47). From that, cell
surface staining was done in 1974 (48), proteins in live cells were seen in 1978 (49), and
intrinsic fluorescence (unlabelled protein) imaging done in 1995 (50). Lateral diffusion
of objects in a membrane was best described theoretically by Saffman and Delbrück in
1975 (51) as cylindrical objects diffusing freely in 2 dimensions. Experimental work to
10

observe lateral diffusion can be done by FRAP, and the most complete description of this
method is given by Axelrod, Webb, and coworkers in 1976 (52). For supported lipid
bilayers, an excellent mimic of 2-dimensional membranes, pioneering work into creation
and characterization has been done by Tamm (53,54) and McConnell (54).
FRAP has been used extensively to characterize biological dynamics. The
publication by Axelrod, Webb, and coworkers (52) has been cited over 1900 times as of
this writing (55). In 1982, Webb and coworkers showed that constraints to lateral
diffusion of lipids and receptor molecules are relaxed in blebs of muscle cell membranes
(56). The diffusion of voltage-dependent sodium channels is restricted to the axon
hillock of neurons with no diffusion to the cell body. This was shown using FRAP in
1988 by Elson and coworkers (57). FRAP has played a crucial role in studying the
presence of lipid domains in cells (58,59,60,61), a topic that remained controversial
throughout the 1990s and into the 2000s. In recent medical research, FRAP has been
used to study interstitial transport of drugs across cancerous tumor boundaries toward
target cells (62), identify an association of influenza viral proteins with membrane rafts
(63), and image the transcription cycle of HIV-1 (64). Assays including fluorescence
remain an integral part of the analytical toolkit used to study biologically interesting
phenomena.
The State of the Art in Membrane Curvature Sensing
To get an understanding for the state of the art in curvature sensing assays, I will
highlight four different methods already established. As discussed earlier, separating
curvature from confounding variables within a cell is difficult. All of these methods seek
to control curvature through a variety of variables that mimic cellular conditions. By
11

Figure 5: Details of the SLiC assay. A) Isolated liposomes are immobilized on a glass
surface with biotin/streptavadin. B) Confocal image of a heterogeneous sample. Scale
bar is 10 μm. C) Total integrated fluorescence for the liposomes indicates size. D)
Binding molecule fluorescence over the same area as C. To normalize for the size of
the liposome, the density of the binding molecule is calculated by dividing integrated
intensity in D over C. Scale bar in C and D is 1 μm. Figure used with permission (3).
discussing these methods and their advantages/disadvantages, I will highlight how the
present work maximizes the advantages, minimizes the disadvantages, and introduces
new capability beyond what is already known. This biosensor is the first to observe
large-scale 2-dimensional diffusion of biomolecules on a supported lipid bilayer with
small radii of curvature in equilibrium with flat areas of fluid bilayer. This enables
unprecedented observation of the influence of physical structure on dynamic sorting.
Liposomes can be particularly useful in curvature investigations because they
have a single defined curvature determined by the diameter of the vesicle. Liposomes
have been used as models for biological membranes (65). A more recent assay, the
single liposome curvature (SLiC) assay, tethers liposomes to a glass surface with
sufficiently low density to resolve individual vesicles (66). Figure 5a (3) schematically
demonstrates this method. These liposomes are labeled with fluorescent lipids, such as
Texas Red DHPE, and the relative fluorescence used to determine size. Using a second,
spectrally separated fluorophore on a protein of interest, the amount of binding can be
12

quantified. Figures 5b-c show an example confocal image and the ratio used to
determine curvature sensing molecule density. In this study (3), researchers used this
method to investigate amphipathic motifs binding to curvature. They revealed that
binding is mediated by number of binding sites, not increased affinity as would be
predicted. The primary advantage of this system is that it uses single liposomes, which
illuminates more population information than ensemble studies. A major disadvantage is
that the different radii of curvature are isolated. This eliminates dynamic exchange of
bound motifs along the surface, which does not mimic membranes in organelles or the
plasma membrane.
Following a different track with using liposomes, another method takes giant
unilamellar vesicles (GUV) and pulls out long tubes via micropipette aspiration (67). As
a tube is pulled from the GUV, the size of the tube is determined by the rigidity of the
bilayer and the pulling force exerted on the tube. More rigid bilayers lead to larger tubes,
and increasing the pulling force decreases the size of the tube. The radius, R (m), of
these pulled tubes is described by the bending rigidity of the bilayer, κ (N·m), and
membrane tension, σ (N/m), as
(Eqn. 1)
Tension then is dependent on the pulling force, f (N), as
(Eqn. 2)

13

Therefore, by controlling the pulling
force, the radius can be controlled (59). Figure 6
(59) is a brightfield image of this method in
action. The researchers here were able to study
lipid sorting into ordered and disordered phases
and the ability of those phases to form tubes.
After studying rigidity of these phases, the
experimenters verified the assumption that tubes
are typically pulled out of disordered, less rigid
phases. A second study with this method (9) was
able to demonstrate N-BAR domains ability to
sense curvature at low concentrations but
Figure 6: A GUV is aspirated to a
pipette on one end and attached via
biotin/streptavidin to a bead trapped
in optical tweezers on the other. In 23, the GUV is gently withdrawn and a
tube is formed between the GUV and
the bead. The tension on the pipette
controls the size of the tube. The
scale bar is 10 μm. Figure used with
permission (59).

generate curvature at higher concentrations. A
major advantage of these methods is that it
mimics curvature changes induced by
cytoskeletal activity (59). Secondly, tension can
be used not only as an inducer of curvature, but
a sensor for curvature changes, as in the second

study (9). Disadvantages of this method include the need for specialized equipment, the
limited ability for lipids to exchange with the ‘bulk’ GUV (9), and like the liposome
method, a failure to mimic curvature on large-scale, 2-dimensional surfaces such as the
plasma membrane in the areas imaged, the extended tube. Additionally, only ensemble
dynamics through fluorescence recovery after photobleaching (FRAP) are accessible in
14

this method due to the large percent
fluorescent lipid needed (1%), thus single
particle tracking is not possible.
Mimicking this large-scale, 2dimensional surface is the primary advantage
of the final two methods presented. Using
soft lithography, researchers were able to
pattern glass with a regular, wavy surface.
Figure 7 (4) demonstrates the topography of
this setup. Lipids are added via liposome
deposition, a standard supported lipid bilayer
(SLB) technique. Using atomic force
microscopy (AFM), the glass surface
curvature is characterized, which in this
study had a maximum radius of curvature of

Figure 7: Topography of glass surface
taken. A) Schematic cross-section
showing relevant distances. B) Widefield
image of the surface. C) AFM image (note
scale change). D) Surface profile of C.
The inset shows the change in curvature
corresponding to the boxed area. Figure
used with permission (4).

55nm. The SLB molding around the surface
waves is assumed. The wavy nature of the surface allows a continuous transition from
positive curvature to negative curvature. Fluorophore labeled proteins are visualized with
confocal microscopy and correlated to the AFM images. Mimicking 2D surfaces,
transitions between extents of curvature, and presence of a large reservoir of lipids are
major advantages of this method. This method also clearly creates areas of negative
curvature. Preparation of the surface is the major disadvantage. Preparation requires
harsh surface etching (HF, NH4F, CF4, and O2 plasma), high temperatures (200°C), and a
15

prefabricated polydimethylsiloxane mold. The requirement of this mold makes changing
the surface topology in multiple experiments non-trivial. Additionally, the process of
determining curvature is separate from the process used to investigate protein location
and motion. This requires an additional method to correlate the two. This work
interestingly found curvature sensing properties of various proteins (ENTH, N-BAR, and
CTB) when the bilayer was saturated, yet single-molecule imaging showed no curvature
sensing. This implies a cooperative aspect to curvature sensing.
The final established method I highlight also uses lithography to pattern a glass
surface with curved morphology (60). Charged polymer nanoparticles (NPs) will self
assemble into ordered arrays on an oppositely charged glass surface. Subsequent thermal
treatment will anneal the particles and systematically change the radius of curvature of
the particles with respect to the treatment time. An SLB can be formed over this
structured surface via liposome deposition. Figure 8 (8) shows scanning electron
micrographs of the top (a) and side (b-d). Using FRAP, the researchers observed various
diffusion constants of bilayers over the patterned surfaces. Contrary to expectation, they

Figure 8: Series of SEM images showing a sensor made from colloidal lithography. A)
Overhead image of 110 nm particles heated at 110°C. B-D are side views of the
particles and show the effect of higher temperatures, which causes the radius of
curvature to decrease. B) 110°C C) 114°C D) 118°C. Figure used with permission
(8).
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found that more highly curved bilayers had larger diffusion constants. The authors
speculated that alleviating of packing constraints at sites of positive curvature was
responsible for increased diffusivity. This method is able to easily control the radius of
curvature via temperature and simulate a 2D surface. Curvature was not correlated to the
spatial organization of the lipids though. Nanoparticles were not fluorescent nor was
correlated AFM done, so the influence of curvature at specific sites could not be
investigated. Without this, only the general effect of curvature, and not the spatial,
morphological influence, can be investigated.
Through our efforts, we seek to further understand the transient interactions
between regions of membrane curvature and proteins/lipids. We characterize protein and
lipid sorting to curved surfaces, lateral movement, colocalization with pertinent features,
and isoform effects. To accomplish this, we have developed a novel biosensor that
mimics biological membrane curvature, and demonstrates the application of the biosensor
to various lipids and a protein suspected of curvature sensing properties, C-reactive
protein (CRP). This new biosensor has notable advantages over the sensors currently in
use. 1) Most notably, this biosensor spatially resolves the interaction between protein,
lipid, and sites of curvature. It mimics the surface of blebs and budding endocytoic
vesicles by having isolated sites of curvature in dynamic equilibrium with a bulk, flat
bilayer section. 2) The preparation is quick and simple. 3) Due to the independently
resolved extents of curvature, our system can have inherent heterogeneity. This
heterogeneity permits molecules of interest to sort dynamically into regions of curvature
with a high degree of specificity. This gives us refined information about molecular
sorting. 4) Chemical composition of the bilayer is controlled independently from the
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curvature generating mechanism. 5) The sensitivity of the biosensor is high enough to
detect single molecules moving on the surface.
This dissertation is divided into six chapters. Chapter two describes the methods
and materials used to conduct the experiments. Some terminology is also discussed. In
chapter three, we discuss data from characterization of the biosensor and control
experiments conducted. Chapter four focuses on the implications of lipid sorting into
curved SLBs and the diffusion of curvature sensing lipids. Chapter five discusses our
investigations into CRP conformation conversions and curvature sensitivity. Finally,
chapter six summarizes the major results.
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Chapter Two: Methods
Formation of the biosensor was a modification of established supported lipid
bilayer (SLB) techniques (61). Lipid composition was controlled at the time of SLB
preparation, and this was separate from preparation of the physical shape of the surface.
Surfaces were prepared by a rigorous cleaning method and colloidal deposition of
polystyrene nanoparticles (NPs) onto a glass substrate. SLBs were formed around the
NPs which caused the bilayers to conform to the NP surface, thus inducing a desired
curvature. In future uses of this sensor, proteins and molecules of interest can be added
after SLB is formed. This dissertation includes a proof of this concept using C-reactive
protein (CRP).
In this chapter, we describe the methods used to create and characterize the
biosensor. The primary methods were microscopy techniques (total internal reflection
and confocal fluorescence), but other fluorescence techniques were also used to
supplement microscope images. These methods were used to assess fluidity of bilayers
and to perform controls. These results show our system is congruent with work presented
in literature.
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Protocol for Biosensor
Formation
Films were prepared by
mixing the relevant lipid
combination in chloroform. Our
typical lipid composition
consisted of 98%
phosphatidylcholine (PC) lipids
harvested from soy (Soy-PC), and
2% fluorescent lipid, percentages
by mole. We primarily use three
fluorescent lipids: Marina Blue 1,2-Dihexadecanoyl-sn-Glycero3-Phosphoethanolamine (MBFigure 9: Molecular structures of the three dyelabeled lipids used in this work. A) MB-DHPE, B)
Fl-DHPE, and C) Fl-HDA

DHPE), Fluorescien - 1,2Dihexadecanoyl-sn-Glycero-3-

Phosphoethanolamine (Fl-DHPE), and Fluorescien hexadecanoic acid (Fl-HDA).
Structures of these lipids are shown in Figure 9a-c, respectively. Soy-PC includes a
distribution of tail lengths and degrees of unsaturation. A typical carbon-to-degree of
unsaturation distribution of tails is 16:0 (14.9%), 18:0 (3.7%), 18:1 (11.4%), 18:2 (63%),
18:3 (5.7%), and unknown (1.3%) (Avanti Polar Lipids, Lot 840054). The structures of
the lipids in this mixture are shown in Figure 10a-e, respectively. Stock lipids were
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dissolved in chloroform and stored until use at approximately 10 mM concentration.
Total number of moles for each film was 250 nmol. Appropriate volumes to obtain the
98:2 mole ratio were mixed in filtered chloroform and vacuum dried overnight to
evaporate the chloroform. Other lipid mixtures could also be obtained by adjusting the
98:2 ratio as needed. Films were then stored for 3-4 months under nitrogen at -20°C.
Chloroform was filtered through alumina and stored at -20°C prior to use with any lipid.
Inorganic chemicals were purchased from Sigma-Aldrich, lipids from Avanti Polar
Lipids, and biological chemicals and proteins from Life Technologies.
Surfaces were prepared via rigorous cleaning and patterned using NPs prior to
SLB formation. 8-well dishes were purchased from Lab-Tek (#1.0 or #1.5 glass). First,
both sides of the glass plate were immersed in 0.1% sodium dodecylsulfate (SDS, w/v)
for one hour. Second, both sides were immersed in 1.0% bleach solution (v/v) overnight.
Slides were stored under millipore water for up to 1-2 months. This pre-cleaning is
necessary to remove larger contaminants, such as dust and oils. Immediately prior to use,
the upper surface was covered in 100μL of 2% Hellmanex (v/v, a proprietary alkaline
cleaning solution from Hellma Analytics, Müllheim, Germany) for one hour. At this
point, the glass was further patterned using NPs or used for SLB formation as a flat
surface.
In this work, three sizes of polystyrene NPs were used: 40 nm, 100 nm, and 200
nm in diameter (Life Technologies). For imaging, NPs were diluted to a level where NPs
were not clustered. Dilutions used were 1x10-6, 1x10-4, and 1x10-3, by volume from
stock, respectively. Initial stock concentrations were 1% (w/v) solids. This resulted in
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approximate bead dilutions for 40, 100, and 200 nm beads as, respectively: 7x108, 4x109,
and 5x109 beads/mL. Dilutions were made in a deposition buffer consisting of 30 mM
HEPES, 2 mM CaCl2, and 140 mM NaCl at pH 6.4. Diluted NPs were incubated in the
wells for 15 minutes, and then the solution was removed. NPs were adhered only lightly
to the surface, so we did not rinse. A linker molecule to facilitate NP attachment is not
recommended, as this will interfere with bilayer fluidity (Figure 14). This preparation
was sufficient for NPs to act as patterns for SLB formation and curvature.

Figure 10: Molecular shape of the dominant species in soy PC and major constituent
of supported lipid bilayers.
We used the following procedure to create fluid SLBs. A dried film, typically
250 nmol, was immersed in 2 mL of deposition buffer and sonicated for 15 minutes using
a probe sonicator on low power. The sonicator consisted of a Fisher Prove Dismembrator
Model 100 attached to an Ultrasonic Convertor probe head (Serial number: FS3406).
Pulsed sonication for 0.1s on and 0.1s off was also used to prevent heat buildup. This
method creates a heterogeneous mixture of unilamellar and multilamellar vesicles that
will adhere to glass and rupture, forming a lipid bilayer over the glass. This method
forms a single bilayer over the glass surface (Figure 19). After sonication, 100 µL of the
vesicle solution was added to NP prepared wells and incubated for 1 hour at 37°C. The
surfaces were then cleaned of excess liposomes by sequentially adding 100 µL of
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deposition buffer, then removing 100 µL. This process left the surface wet at all times,
and was repeated a total of three times. The SLB was formed and ready for direct
imaging, or for addition of protein. If CRP was added, 100 µL of deposition buffer was
accounted for as a dilution factor.
To prove this method creates only a single bilayer, fluorescence of 1-palmitoyl-2[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)-amino]dodecanoyl]-sn-glycero-3phosphocholine (NBD-POPC) can be quenched using sodium dithionite. This procedure
has been done previously using bilayers formed around silica nanoparticles (68). The
SLB was formed in 8-well plates as usual over a surface without NPs with 100 μL of
deposition buffer in the well. 10 mM sodium dithionite was prepared in deposition
buffer. One frame prior to dithionite addition is taken to get a baseline of fluorescence.
10 μL of dithionite solution (to a final concentration of 5 mM) was added to each well
and quickly mixed by pipetting up and down. The first image after addition was taken as
quickly as possible, approximately 20 seconds after addition. Five additional images
were taken at 1 minute intervals. This prevents photobleaching of NBD and allows for
refocus to prevent microscope drift. Mean intensity of fluorescence was measured in a
10μm x 2μm box positioned to avoid liposomes. The curve was normalized to the
intensity before addition of dithionite solution.
Preparation of mCRP
Modified CRP (mCRP) was prepared in three ways. Native CRP is purchased
purified from human serum from Academy Biomedical Co. The first two methods, urea
and heat, denatured CRP to similar molecular weights (MW) when run on a native gel;
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both run at smaller MW than native CRP (pCRP) and higher MW than fully denatured
CRP (69). All three methods have similar denaturing curves in fluorescence assays. In
the first method, pCRP was treated with heat and SDS (mCRP in most sections,
mCRPSDS in section: Aptamer Specific to mCRP). pCRP was diluted to a desired
concentration (typically 1μM) in 0.01% SDS in deposition buffer. This was heated at
80°C for 1 hour. In the second method, pCRP (typically 1μM) was put in a solution of
8M urea and 10 mM EDTA and incubated at 37°C for 2 hours. Then using 3500 MW
cutoff (MWCO) dialysis tube, mCRP was dialyzed against 2 L PBS at 4°C for 2-3 hours.
We repeated dialysis a total of 3 times. The final dialysis was run overnight. When
needed, mCRP was concentrated using a 10k MWCO, spun at 5000G for 10 minutes. In
the final method, using guanidine hydrochloride (GndHCl), pCRP (typically 1 μM) is
incubated with 1M GndHCl for 90 minutes at 37°C. These conditions were selected
because we observed efficient conversion to mCRP via gel electrophoresis analysis.
A fourth treatment to modify CRP was also done using HCl, though this CRP
isoform does not bind C1q. pCRP was incubated in an acidic solution (10 mM 4-(2hydroxyethyl)-1-piper-azineethanesulfonic acid (HEPES), 0.1 M HCl, pH 2) for 5 min
and neutralized with 0.1 M NaOH. A detailed explanation for the use of this isoform is
in the section: Aptamer Specific to mCRP, and this isoform is refered to as mCRPHCl.
CRP–aptamer complexes were prepared by incubating the relevant CRP isoform
with RNA aptamer in binding buffer (20 mM HEPES, 140 mM NaCl, 50 mM KCl, 0.1
mM DTT, and 5% glycerol at pH 6.5). Incubation was carried out at room temperature
for 20 min and analyzed immediately. While calcium is not necessary for aptamer
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binding, 2 mM CaCl2 was added to the pCRP sample to retain its folded pentameric
structure.
Typically in studies on CRP, this conformational change is often refered to as an
“isoform change” (70) (71) (72) (73). This work will continue the use of this
terminology, though we recognize that the use of “isoform” is slightly incorrect. The
term typically refers to similar proteins resulting from different genes or through
alternative gene splicing (74). Technically, the change to CRP discussed here is a
conformational change.
Polyacryalmide Gel Electrophoresis
Native polyacrylamide gel electrophoresis (native PAGE) was used to determine
the isomeric state of CRP. Denaturing gels cannot be used, as they denature pCRP,
causing it to run at a similar position as mCRP. The procedure to pour a native 10%
polyacrylamide gel follows. We prepared a gel apparatus with thickness of 1 mm. For
the resolving gel, we mixed 3.35 mL of 30% bis-acrylamide (29:1) solution, 2.5 mL
1.5M Tris (pH = 8.8), and 5 µL 10% (w/v) SDS in a 15 mL tube. This was filled to 10
mL, vortexed, and then we added 10 µL TEMED and 100 µL 10% APS. This final
mixture was quickly poured into gel apparatus. We covered the wet gel with a small
amount of ethanol and let it stand for 1 hour. Afterwards, we poured off ethanol before
addition of the stacking gel. For the stacking gel, we mixed 500 µL 30% bis-acrylamide
(29:1) solution, 375 µL 1M Tris (pH = 6.8), and 1.5 µL 10% (w/v) SDS in a 10 mL tube.
This was filled to 3 mL, vortexed, and then we added 6 µL TEMED and 30 µL 10%
APS. This final mixture was quickly poured into the gel apparatus over the resolving gel
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and we inserted the comb. After 30 minutes of standing, the gel was ready for use. We
stored them damp at 4°C.
When running the gel, we first prepared 1 L of a running buffer containing 40
mM Tris (4.856 g/L) and 189 mM glycine (14.188 g/L). We assembled the running
apparatus as directed using a prepared gel and running buffer. To prepare mixtures for
running, we mixed 10 uL of protein with 5 uL of loading buffer (Biorad, 50% glycerol
and bromophenol blue). Typical protein concentrations were around 500 nM pCRP (57
µg/mL of CRP). Each well was loaded with 12 µL. We loaded only 5 µL of a protein
standard or ladder to a well. The gel was run at 80 V until the sample entered the
resolving gel, and then ran at 100 V for approximately 2.0 to 2.5 hours or until the
bromophenol blue reached the bottom of the plate.
To fix and silver stain the gel, the following solutions were prepared. All required
25 mL total per gel and were made in Millipore water:


Fixing solution: 50% methanol, 5% acetic acid, 12.5 µL of 37% formaldehyde
per 25 mL.



Sensitizing solution: 0.02% sodium thiosulfate. This was made fresh daily,
and was made from a fresh 10% solution.



Silver stain: 0.2% silver nitrate



Developer solution: 6% sodium carbonate, 100 µL of 10% sodium thiosulfate
per 25 mL, 50 µL of 37% formaldehyde per 25 mL



Stopping Solution: 50% methanol, 5% acetic acid
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Once a gel was run, we removed it from the apparatus and gently pried apart the
gel plates. First we immersed it in 12.5 mL of fixing solution to separate the gel from the
remaining plate. We let it sit for 15 minutes, and then replaced the solution. The gel was
washed three times with 50% methanol for 8 minutes each. Then it was immersed in
sensitizing solution for exactly 1 minute. This was washed three times with Millipore
water for 20 seconds each. The gel was stained using silver stain for 30 minutes. Again,
it was washed twice with Millipore water for 30 seconds each. To develop the bands, the
gel was immersed in developer solution until bands visibly appeared, typically around a
minute. This reaction was quenched with stopping solution by swirling gently. The gel
was rinsed with 50% methanol for 10 minutes. One final rinse was done with Millipore
water. The gel was imaged immediately, but it can be stored at 4°C in a damp container
if desired.
The electrophoretic migration of free 3′Cy5-RNA and bound CRP-3′Cy5-RNA
complex were observed using nearinfrared (NIR) imaging of the wet gel using the 700
nm channel on an Odyssey imager and CRP protein was visualized by subsequent silver
staining of the same gel. The binding affinity of the RNA aptamer to CRP was analyzed
using an EMSA. Increasing amounts of 3′Cy5-RNA (0.48-3.8 μM final concentration)
were incubated with CRP (fixed at 23 μg/mL) in binding buffer for 20 min at room
temperature before electrophoresis. The CRP–aptamer complex was loaded on a 5%
polyacrylamide gel (19:1) in 0.5×TBE (45 mM Tris, 45 mM boric acid, and 1 mM
EDTA) and electrophoresed at 110 V for 40 min at 25 °C.
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Confocal Microscopy
Confocal microscopy was performed using an Olympus FV1000 laser scanning
confocal microscope using a 100x oil objective (NA = 1.4). An excellent review of
confocal microscopy theory was published (75). Briefly, this method of microscopy
illuminates a small volume with laser light and collects fluorescence from the same
volume, thus reducing out of focus light and increasing signal to noise. In this work, we
used three channels of fluorescence. Red channels, typically NPs, were excited with 594
nm diode laser; green channels with 488 nm; and blue channels with 405 nm. Images,
sized 512x512 pixels from a spatial area 42x42 microns squre, were taken raster-style
using a photodiode detector, typically with a dwell time of 12.5 µs per pixel. Laser
power, zoom, gain, and detector sensitivity were all adjusted as needed to obtain high
quality images. Each channel was collected sequentially to eliminate image
bleedthrough. Images were analyzed in ImageJ (76).
Resolution for this microscope is at the diffraction limit, approximately 220 nm
for red emission light, centered at 610 nm. For fluorescein, the diffraction limit is
approximately 185, centered on 516 nm. The exact equation to calculate the absolute
diffraction limit is:
(Eqn. 3)
where λ is the wavelength of the observed light and NA is the numerical aperture of the
collecting objective. For our system, the NA is 1.4. This distance, d, is the minimum
size of an airy disc from the peak to the first diffraction minimum. If two emission
sources were closer than d in space, the central maxima of their airy discs would overlap,
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making resolution of the sources impossible. We define resolution as the minimum
distance the centers of two spots must be from each other to be considered distinct spots.
Spots in this work are defined as a 12 pixel area. This is a circle with a 320 nm diameter.
Our spot size conservatively presumes a size slightly larger than this absolute optical
minimum. If the airy disc is approximated as a Gaussian instead of a Bessel function, our
collection diameter would collect 97% for red emission light and >99% for green
emission light.
Confocal microscopy was also used for fluorescence recovery after
photobleaching (FRAP) studies. In this method, a selected area is illuminated with the
appropriate laser at high power, typically 100%, to bleach the local fluorophores. The
changes to the spatial distribution of bleached and unbleached fluorophores indicate
fluorophore movement, and thus can be used to examine membrane fluidity and protein
movement. In this method, frames of fluorescence are taken at regular time points. Each
frame consists of a 512x512 set of pixels observing fluorescence from a spatial area
42x42 microns square. For our work, FRAP curves were typically obtained by imaging 3
initial frames, bleaching a selected area for 5 frames or ~500 to 1000 ms, and then
imaging 17 or 37 more frames to obtain the recovery. All published work was measured
for 37 frames to improve accuracy of data fitting. Pre- and post-bleach frames were
imaged at 2µs per pixel. Bleached areas are circles with 125 pixel diameters. Prior to
analysis, all FRAP images were adjusted for overall image photobleaching by correcting
average intensity to a reference area outside the bleached area. A correction factor was
obtained from this outside area by dividing the average intensity at a given time point by
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the intensity in frame 1. This factor is the percent drop in intensity due to overall image
bleach. The average intensity inside the FRAP area is then divided by this factor for each
time point. This corrects all intensities up by a sliding scale based on the total reduction.
TIRF Microscopy
Total internal reflection fluorescence (TIRF) microscopy is a technique that
selectively illuminates the closest 100 nm of solution to the glass surface with an
exponentially decaying evanescent field. The critical angle, θc, for total reflection is
dependent on the difference in refractive index between the glass, n2, and water, n1,
solution as:
(Eqn. 4)
When the ratio of indices is less than 1, total internal reflection occurs. The illumination
depth is dependent on the angle of the illumination laser. When this laser is totally
internally reflecting, an evanescent field above the glass is created. The rate of decay of
this field is dependent on the angle of the illuminating laser, θ, and decays as:
(Eqn. 5)
where
(Eqn. 6)
The term λ0 is the wavelength of laser light in vacuum. This method has exceptionally
high signal-to-noise ratios, making it ideal for single particle tracking. A full review of
the technique was published (77). Our experiments were performed on a Nikon Eclipse
Ti-U equipped with a TIRF/Epifluorescence illuminator and a 60x TIRF oil objective
(NA = 1.49). Images were acquired using an Andor iXon EMCCD with a typical frame
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capture time of 200 ms. Two emission channels were available for use on this
instrument, red and green. Red channels were excited using a 561 nm diode laser, while
green channels were excited using a 491 nm laser. Channels can be imaged
simultaneously using a DualView or sequentially using separate filter sets. The former
was best for tracking studies while the latter was used in static investigations. Once
images were collected, they were analyzed using ImageJ. Protocol for TIRF use is in
Appendix B.
CRP binding to aptamer was assessed using TIRF microscopy. Individual
chambers were created using CoverWells (Life Technologies, Eugene, OR) that were cut
and adhered to cleaned coverslips (No. 1 thickness, Ted Pella). Coverslips were coated
with monoclonal, nonspecific anti-CRP antibody (C6, 1:1,000 dilution in 30 mM sodium
carbonate/70 mM sodium bicarbonate) for 1 h at room temperature, blocked with 3%
BSA for 2 h, and rinsed 3× with 0.01% Tween-20/PBS buffer, and 1× with PBS. CRP
(mCRP or pCRP, 6 μg/mL) was preincubated with 0.3 μg/mL of 5′Cy3-RNA in binding
buffer for 20 min at room temperature. The samples were then added to each well,
incubated for 10 min, rinsed 3× with 20 mM HEPES/140 mM NaCl buffer to remove
unbound material, and imaged immediately. Excitation of Cy3 was performed using a
fiber launch (Solamere Technology Group, Salt Lake City, UT) equipped with an AOTF
to shutter the excitation from a 50 mW, 561 nm diode pumped solid-state laser (Cobalt
Jive 50, Cobalt AB, Sweden). Emission was filtered using a 570-nm long pass dichroic
(Omega Optical, Brattleboro, VT) and a band pass filter (605/55, Chroma Technology,
Bellows Falls, VT). The images were acquired on an Andor iXon EMCCD with an
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exposure time of 200 ms and an EMgain of 200 using freely available software
(μManager (78)). Each image was filtered using a rolling ball filter (ball radius of 10
pixels) to eliminate background noise and correct for image tilt. The intensity was
integrated across the full image to obtain a reading of total fluorescence. TIRF
microscopy data are presented as mean ± SE from at least five independent images. A pvalue of <0.05 using a Student’s t test was considered as significant.
Fluorescence Assays
Steady-state fluorescence techniques were used to illuminate changes to protein
structure and binding. The intrinsic fluorescence associated with tryptophan residues in
CRP were used for these studies. Both max intensity and peak shift will change in
response to the solvent environment the tryptophan is in. As residues transition from a
hydrophobic environment to an aqueous environment, the fluorescence decreases and is
red shifted. CRP has 30 tryptophan residues in the native, pentameric structure making it
a suitable candidate for fluorescence assay development. We used fluorescence scans
and anisotropy to investigate the unfolding of CRP. For both assays, CRP was excited at
280 nm and emission collected in a 5 nm window centered on 330 nm. Scans were done
on CRP at various stages of denaturing according to the three methods used in this work.
In the first method, fluorescence was read at 5 minute intervals from 0 to 90 minutes
while heating in 0.01% (w/v) SDS at 80°C. In the second method, fluorescence was read
for 1 M increments of concentration from 0 to 8M urea at 37°C for 2 hours. In the final
method, fluorescence was read for 0.2 M increments of concentration from 0 to 2.6 M
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GndHCl at 37°C for 90 minutes. Fluorescence scans were performed on a Tecan Infinite
M1000 plate reader using 200 μL per well.
Anisotropy binding studies were performed on a Perkin Elmer LS55 fluorometer
in a quartz cuvette with excitation and emission wavelengths of 555 and 570 nm and slit
widths of 2.5 and 10 nm, respectively. Baseline anisotropy of the 5′Cy3-RNA was
acquired for 5 min. Changes in anisotropy were measured after normalizing to the initial
anisotropy of the 5′Cy3-RNA aptamer in buffer. CRP was then added to the cuvette and
incubated for 5 min at room temperature before anisotropy measurements were taken.
For the displacement assay, titrations of an unlabeled ssDNA aptamer (79) were added to
the CRP-5′Cy3-RNA complex and the measurements were taken immediately. Final
concentrations of CRP and 5′Cy3-RNA were 9.1 and 0.59 μg/mL, respectively.
Tabulated data were reported as mean ± SD from three independent experiments.
Dot blot assays were prepared to provide direct evidence of aptamer binding to
CRP. A 2 μL aliquot of protein was blotted on nitrocellulose membrane, air dried and
blocked with 3% BSA+0.05% Tween-20/PBS overnight at 4 °C. After washing 3×with
0.005% Tween-20/PBS, the membrane was probed with 170 nM (2.38 μg/mL) 5′biotinRNA aptamer for 1 h at 25 °C followed by a 30-min incubation with 1:1,000
streptavidinconjugated IR800 and imaged on an Odyssey imager (Li-COR
Biotechnology, Lincoln, NE).
Ministack Analysis
Colocalization has traditionally been a difficult quantity to measure (80).
Therefore, we developed a procedure in MATLAB, dubbed Ministack, to compare two
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fluorescent channels. In this procedure, one channel was designated as the standard for
finding spots. In this work, we used NP channels as spot standards, but any channel with
sufficient signal-to-noise and biological justification could act as the spot standard. In the
standard image, spots were located by finding the local maximum in a designated size
above a threshold. For our work, we choose a threshold of 500 for 200 nm spots, 250 for
100 nm spots, and 100 for 40 nm spots. Size of spots was selected as 9 pixels. This is
larger than random noise, but smaller than expected for a diffraction limited spot. A
25x25 pixel area around this maximum is then cut out in the standard channel. Using
these maxima, a corresponding spatial location was cut out in the other channels. These
two (or more) stacks were then directly compared where each slice pair is a single spatial
location. To assess overall colocalization, we averaged each pixel in the 25x25 pixel
frame across all slices to give a single, averaged, 25x25 pixel image. These final images
showed the average intensity over locations determined by the standard image. If there
was colocalization, the second (or third, etc) channels will have increased intensity in the
center of the image. Conversely, if there is anti-colocalization, the channels would have
had decreased intensity in the center. No preference would have shown an even intensity
pattern in the non-standard channels (81). The typical signal-to-noise associated with
this method is approximately 300, calculated by taking the mean peak height and dividing
by the standard deviation of the background.

34

Chapter Three: Sensor Characterization
This chapter details the development and characterization of a novel biosensor to
investigate the curvature sensing properties of biologically relevant molecules. This tool
will enable us to probe the effect of curvature independent from the chemical
composition of the bilayer. We achieved three main goals during the development of this
biosensor. First, we designed and characterized the lipid covered surface and assessed
the fluidity of the lipid bilayer, which is the subject of this current chapter. Second, we
investigated the influence curvature has on sorting lipids with different head and tail
compositions. Finally, we applied our biosensor to C-reactive protein (CRP), a protein
involved in inflammation, and one that potentially has curvature sensing properties. This
chapter focuses on the design and characterization of the biosensor.
Using Nanoparticles to Form a Patterned Substrate
Since particles are below the diffraction limit, we first sought to target a specific
spot density so that red fluorescent, carboxyl-modified polystyrene NPs are isolated from
each other and can be spatially resolved. Stock solutions have rather narrow size
distributions. 100 nm NPs have a reported size standard deviation of 5 nm. At high
nanoparticle (NP) concentrations, NPs will cluster (82) and form irregular shapes (83)
which would give unknown protuberances to the bilayer. Figure 11a and b show a
typical pair of images. Target density of NPs is between 0.05 NP/μm2 and 0.1 NP/μm2.
At this density, a majority of spots in the NP channel are isolated NPs, which is
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confirmed by a histogram of the average intensities of individual spots (Figure 11c).
Intensity indicates particle size, and a monodisperse field of particles will have a narrow
distribution. If multiple particles are in a single spot, the intensity of the given spot
would be a multiple of the average intensity of a single NP. To confirm we have only
single particles, we measured the distribution of spot intensities and analyzed the
histogram in two ways.

Figure 11: A histogram analysis of two images shows that the majority of spots are single
NPs. A and B) Two separate images showing the stochastic nature of NP (100 nm)
deposition. 42x42 μm2. C) Histogram and statistics of average intensity of fluorescence
of individual spots.
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In the first method, we use the t-distribution and a Student’s t-test to check if the
observed distribution is binomial with two proposed peaks as multiples of each other.
This second peak will be assumed to be at twice the intensity of the median of the
primary peak. The median is used instead of the mean to limit the effect of outliers.
Additionally, we assume this cluster peak has the same variance as the observed peak.
With these assumptions, a Student’s t-test can be performed. This tells us if our observed
peak is distinct from the hypothetical 1st cluster peak. If it is not, then we cannot assume
that our image has a 1st cluster peak. The calculated test statistic is t = 2.83, which is
larger than the t-statistic (=1.96 for large n, α = 0.05). Therefore, our assumption of a
binomial distribution is invalid. Another way to conceptualize this result is to consider
that only 3.5% of spots are within 1 standard deviation, σ, of the hypothetical 1st cluster
peak. Yet a third way is to consider that only 2.2% of spots are more than 3σ (the
fluorescence intensity of the mean + 3σ is 1513, near the hypothetical 1st cluster peak)
from the observed median.
Secondly, we fit this same histogram to two separate models, once as a single
Gaussian and once as a sum of two Gaussians. The first model fit very well. The
calculated mean fluorescence was 847 ± 12.2 (95% confidence interval) with an R2 of
0.927. The second model failed to converge on a solution. Even if the second model was
constrained where the parameters of one Gaussian matched those from the first model, no
solution was found. With these two methods, we can conclude that the curvature of the
lipid bilayer is determined from single particles and fluorescently marked by the locations
of these NPs.
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Fluid Lipids on a Patterned Surface
Once NPs were deposited, SLBs were formed over top. For this sensor to be a
useful mimic of biological activity, the lipid bilayer that is formed must be fluid both in
the flat sections and on top of nanoparticles. Additionally, the presence of the NPs
should not perturb the fluidity. Fluorescence recovery after photobleaching (FRAP) is an
ideal tool to investigate these requirements. For this method, fluorescence is measured
for a specific area with a known shape that has been photobleached by high intensity
laser light. Fluid bilayers recovered fluorescence exponentially. Fluorescence recovery
kinetics are well established, and an elegant mathematical description has been done
previously to relate recovery to lipid diffusion rates (52,84). For circular beam profiles
with known size, the determination of diffusion constants is simplified. The diffusion
constant, D, is related to the square of the bleach radius, r, the half-time, τ½, and a
constant representing motion with a specific bleach shape, γD, as
(Eqn. 7)
For circular bleach areas, γD = 0.88. Half-time is the time required for the recovery to
equal half of its equilibrium value and can be calculated from a fit to the observed
recovery. Fitting to a single exponential can give a characteristic time constant, k, as
(Eqn. 8)
Ft, 0,  are values of fluorescence at a given time, initially, and equilibrium, respectively.
Then half-time is directly calculated from the time constant as
(Eqn. 9)
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Using these values in equation 1, D can be calculated. Figure 12 shows a representative
FRAP series. Here MB-DHPE is recovering over 200 nm polystyrene NPs. Frames were
taken at 1 frame per 0.5 s.

Figure 12: Typical series of FRAP images. A) NP (200 nm) image. B) Series of
MB-DHPE lipid images where the bleach frame is at t=0s. Images are corrected
for overall photobleach, which are then used to calculate relevant fluidity
parameters. All images are 20x20 μm2.
The above technique was used on a variety of nanoparticle sizes. Figure 13
details results showing that NP size has no discernible impact on diffusion constants or
percent recovery. Three different NP sizes were used: 40, 100, and 200 nm in diameter.
The SLB formed for these data was 98% Soy-PC and 2% MB-DHPE. Compared to
recovery over a flat surface, diffusion constants for all particle sizes were not
significantly different from recovery over a flat surface (P-value > 0.19, N=15,
ANOVA). These diffusion constants are of the same order as diffusion constants of
lipids seen in a typical plasma membrane. Above the liquid crystal transition
temperature, lipids in a plasma membrane have diffusion constants approximately 1
μm2/s (85). In SLBs, diffusion constants are approximately 2.0 µm2/s (53) (8). Table 1
shows diffusion constants of various molecules in different environments. Our sensor is
slightly faster than what is reported for lipids in the plasma membrane, but this is
expected due to the lack of transmembrane and insertion proteins that slow membrane
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diffusion (86). Other work with SLBs without proteins (53) report diffusion constants
within error of our observations. Percent recovery had no significant differences for any
particle size either (P-value > 0.06, N=15, ANOVA). Recoveries were high, over 90%
for each surface, and are similar to what is seen in a typical plasma membrane (85). This
indicates that the presence of NPs does not change the mobile fraction.

Figure 13: Presence of NPs does not change fluidity parameters. A) Recovery curves are fit
to a single exponential recovery. B) The mobile fraction is unchanged and has low variance
for each set of trials. C) Diffusion constants were more varied between trials and showed a
higher variance within trials. No statistical significance was observed between trials. Error
bars are standard error.
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It is worth considering what the minimum detectable difference is between two
mean diffusion constants or two percent recoveries. This will give an estimate of how
sensitive our method is to changes in fluidity compared to a flat bilayer. A full
description of this type of calculation can be found in many introductory statistics books.
A useful reference is published (87). The minimum detectable difference in mean
diffusion constant, θ, is dependent on the total sample size, N (or n1 + n2), the standard
deviation, σ (assumed equivalent for two values), the ratio of sample sizes, r (or n1/n2, as
a value greater than 1), and the test statistics for confidence levels selected for Type I and
Type II statistical errors, tα and tβ, respectively. These are related as,
(Eqn. 10)
Calculating θ is a relatively straightforward operation when σ is known from our
observed data. Conservatively, we choose α and β values equal to 0.05. These are
commonly accepted minimum levels for statistical significance. Therefore the test
statistics are 2.145 and 1.761, respectively. The average σ for D between all sample
types is 0.961 μm2/s, and n = 15 for both samples. Using these values, θ is calculated to
be 1.37 μm2/s. For sufficiently large data sets (n = 30 and t-values become z-values), θ
lowers to 0.913 μm2/s. A comparable analysis for percent recovery can be done using an
average σ of 10.2%. Using our conditions of n = 15, θ is 14.5%. For sufficiently large
data sets, θ lowers to 9.69%. The moderately sized θ values reflect the inherent
variability present in SLBs (53). This analysis indicates our biosensor is moderately
sensitive to changes in fluidity though even large data sets would be unable to detect fine
differences in fluidity parameters.
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Table 1: Comparison of diffusion constants from this work to literature observations.
Uncertainty is standard deviation (95% margin of error in parentheses).

Membrane lipids
DMPC bilayer
w/ NBD-DMPE
POPC bilayer
w/ NBD-PC (C-6)
Soy-PC
w/ MB-DHPE
w/o NPs
Soy-PC
w/ MB-DHPE
w/ 40 nm NPs
Soy-PC
w/ MB-DHPE
w/o 100 nm NPs
Soy-PC
w/ MB-DHPE
w/o 200 nm NPs

Experimental D (μm2/s)

Reference

~1.0

(85)

0.94 ± 0.27

(53)

2.61 ± 0.49

(53)

3.70 ± 0.81 (0.41)

This work

3.18 ± 0.93 (0.47)

This work

3.73 ± 0.93 (0.47)

This work

3.98 ± 1.57 (0.79)

This work

A continuous lipid membrane can be formed over NPs of different sizes allowing
a variety of membrane curvatures to be measured simultaneously. In Figure 14, a
continuous supported lipid bilayer with 2% MB-DHPE was formed over 100 nm and 200
nm NPs. Here, red fluorescent 100 nm NPs were mixed with green fluorescent 200 nm
NPs. However, both could be labeled with the same dye and the size could be
determined based on fluorescence intensity (66), allowing another color channel to be
available. The fluidity of lipids on a mixed curvature membrane was similar to flat
membranes; both the mobile fraction (Figure 14b) and rate of diffusion (Figure 14c) are
unaltered. These are also compared to a surface treated with poly-l-lysine. This
treatment, applied after cleaning but before lipids, involves adding concentrated poly-l-

42

lysine to the well. The linked lysine residues are highly positively charged and prevent
movement of biomolecules. This creates a nearly immobile surface.

Figure 14: Multiple sizes of NP (Green, 100 nm and Red, 200 nm) are imaged in the
same sample (panel A, 4x4 μm2). As expected, mobile fraction (B) and diffusion
constants (C) are unchanged. These are also compared to poly-lysine, which makes a
bilayer immobile. This caused a noticeable drop in both parameters.
Determination of diffusion constants is quite sensitive to the number of frames
used to fit against. Initially, we fitted our FRAP data against 17 frames of recovery. Fit
conditions were satisfied, but the calculated half-times for these fits had unacceptably
large margins of error, w (calculated for 95% confidence intervals). Fitting the single
exponential to 37 frames of recovery reduced the margin of error noticeably. For
example, an average fit to 17 frames for a flat MB-DHPE bilayer had an average w equal
to 0.22 μm2/s. Increasing the fit to 37 frames drops the half-time margin of error to 0.14
μm2/s (n=5 for both). This change caused our recovery time to increase from 8.8 s to
19.2 s. The only disadvantages of using more frames are microscope drift at long times
and overall photobleaching at long times. If either the microscope drifts out of focus or
the lipids are completely bleached, a recovery curve is impossible to obtain. Small
deviations in these conditions can be corrected by using an area that is not exposed to the
high intensity laser of FRAP, and determining an overall bleach factor. This factor is
then used to correct the FRAP area for these deviations.
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Surface Characterization and Lipid Contouring
We designed the membrane curvature
biosensor to contain regions of membrane curvature
in continuum with flat membrane. NPs of different
diameters are deposited on a borosilicate glass
surface to give a controlled surface topology. To
form a supported lipid bilayer, liposomes are
sonicated into solution and allowed to fuse on the

Figure 15: Schematic of our
biosensor with multiple extents
of curvature shown.

glass surface (61). This creates isolated areas of curvature defined by single NPs.
Liposome coverage far exceeds the coverage of NPs, so continuous bilayers are formed
from this process. Figure 15 shows a schematic of this biosensor, and the following
section details our characterization of this surface.
Our method is based on previously established SLB techniques, and these
methods require extremely clean surfaces. Figure 16 is a pair of AFM images showing
the change in surface topology before and after the cleaning treatment, which includes
cleaning with bleach, SDS, and Hellmanex, an alkaline cleaning agent. The dirty image
was taken on glass straight from the box. These images were taken and processed using
wet AFM techniques. Surface features prior to cleaning are around 100 nm in height and
are numerous. After cleaning, feature size drops to 3 nm and the frequency of features
also drops. Note that intensity scales for the images are not the same. Line scans below
each image are scaled to the same value and clearly show the reduction in surface
topology after cleaning. Additionally, this cleaning method is not so harsh that new
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features form, like troughs or large shallow pools. With a cleaned, low topology surface,
the next concern would be to ensure the SLB surrounds deposited NPs.

Figure 16: AFM images show a significant drop in surface roughness after cleaning
treatment with Hellmanex. Dirty glass (left) has features nearly 100 nm in height.
Cleaned glass (right) reduces feature size to 3-5 nm. Note that contrast scales on the
two images change to illuminate the different feature topography.

45

To detect changes to bilayer morphology in the presence of NPs, 1 micron
particles were deposited. These particles are larger than the diffraction limit, so a bilayer
coated to the surface of the NPs can be directly observed. Typically, our studies use a
maximum diameter of 200 nm. A rare opportunity to image three clustered 1 μm with
confocal microscopy is seen in Figure 17. In the red channel (Panel A), polystyrene NPs

Figure 17: FRAP of large NPs show lipids surround these NPs. A) A cluster of
three 1 μm NPs is above the diffraction limit. B) Bleaching the lipids (t = 0s) and
observing recovery confirms fluidity around these large NPs. Image size is 4.5x4,5
μm2.
form a triangle pattern. The lipid channel shows the MB-DHPE lipids forming three
distinct circles showing the lipids intercalate between the NPs. The diminished
fluorescence in the middle of each ring shows that the lipids surround the NP. Panel B
shows the FRAP of these lipids imaged at 2 frames per second. After bleach to
background levels, new unbleached lipids refill the bleached areas and show the same
pattern of fluorescent lipids wrapping around the particles. Intercalated lipids exchange
with external lipids. This pattern of recovery is seen for other particles of this size.
Lipids are also observed above the particles. Figure 18 shows another 1 μm
polystyrene NP at three different heights. In the center of the particle, designated 0 nm, a
line scan shows increased intensity on the sides, at approximately 0.9 and 1.9 microns,
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and reduced intensity in the middle. Taking an image 500 nm below this point shows the
lipids converging around the base and the background intensity increasing, indicative of
fluorescent lipids on the surface of the surrounding glass. 500 nm above the midpoint
shows the background at non-fluorescent noise levels, less than 100 a.u., and increased,
even intensity above the particle. Fluorescent lipids are surrounding the NP at all points
in the z-stack. In conjunction with previous work (88), these results demonstrate that the
SLB wraps around and above the NPs, and these lipids are fluid while surrounding the
NPs.

Figure 18: Lipids cover NPs as well as surround them. Lipids surround the NP at
the center (center panel). Above the 1 μm particle (right panel), a line scan shows
that lipids cover the top of the particle. Below the particle (left panel), lipids are
seen merging with the surrounding flat expanse of lipids. The red line shows the
position of the line scan.
Using targeted fluorescence quenching of NBD, we have shown that the SLB
formed for this biosensor is a monolayer, though not perfectly continuous. DHPE labeled
with NBD [2-(4-nitro-2,1,3-benzoxadiazol-7-yl)aminoethyl] can be quenched using
sodium dithionite (68). This is a useful method to determine if our sensor has only a
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single bilayer instead of multilayers. Figure 19 shows the integrated fluorescence
reduction after addition of sodium dithionite. Before the first minute, fluorescence drops
to 50% the initial value, then the rate of drop slows. This initial drop indicates the upper
leaflet of the bilayer is quickly quenched. If there was two bilayers, the initial drop in
fluorescence would have been to approximately 75% of initial fluorescence, and even
less for more multilayers. However, the fluorescence continued to drop after this initial
reduction, indicating that the bilayer formed is not a complete barrier. Trans-bilayer
transport of the doubly
charged dithionite is highly
unlikely, but pores could
make the bilayer
permeable. This biosensor
also creates a bilayer on a
large scale, several
millimeters. It is highly
likely that imperfections
Figure 19: Fluorescence reduction after addition of sodium
dithionite. The quck drop to 50% indicates a single bilayer over this incredibly large
forms. The gradual reduction afterwards indicates that the
bilayer is not completely continuous over the large scale of distance permit dithionite to
several millimeters. Arrow indicates when dithionite was
get under the bilayer.
added.
Fluorescent imaging in multiple channels can potentially be contaminated by
crosstalk and bleedthrough between the various image channels. To address these
concerns, we conducted a series of experiments to assess the image contamination caused
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by these two phenomena. In our context, crosstalk occurs when the excitation laser of
one fluorophore overlaps significantly with the excitation spectrum of a second
fluorophore. Thus the second fluorophore’s emission appears to be that of the first
fluorophore. Bleedthrough occurs when the emission of a fluorophore excited with a
matched laser is sufficiently strong to get past the emission optics of a competing channel
and appear as legitimate fluorescence. Figure 21 is a matrix showing various cross
excitations to determine the impact of crosstalk and bleedthrough. Here we used 200 nm
fluorescent NPs with either red (580/605 nm) or green (505/515 nm) emission as proxies
to determine the relative contribution for each channel. These dyes are proprietary
information of Life Technologies, but the spectra are known (Figure 20). Though this
green emission/excitation is different from the fluorophores we will use (Alexa 488 and

Figure 20: Spectra of green dyes used in this work. All are very similar. Green NPs
have a peak that is slightly red-shifted, making them more susceptible to crosstalk from
the red channel.
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Fluorescein), the spectra are quite similar. The red-shift of the green NPs compared to
Alexa-488 make the NP more susceptible to cross-talk. Images are background
subtracted and fluorescence measured as average fluorescence for a 7-pixel diameter
circle at the spot location. Nanoparticles are the most intense fluorescent objects used in
this work, so these numbers represent the maximum bleedthrough and crosstalk that
could occur. In the first column, this is expected fluorescence for a NP with matched
excitation light and matched emission channel. “Matched” refers to the red
channel/fluorophore excited by a 594 nm laser and the green channel/fluorophore excited
by a 488 nm laser. This is used as a reference for how much that emission light will
contaminate other channels. In the second column, bleedthrough light is assessed by
observing fluorescence with matched excitation but mismatched emission channel. Here,
red has very weak bleedthrough to green (0.18%) but green has significant bleedthrough
into red (25%). This is expected given the overlap in spectra between these two
fluorophores. In the third column, crosstalk light is assessed by observing fluorescence
with mismatched excitation light and a mismatched emission channel. Again red has
very weak crosstalk with green (0.36%). Green’s crosstalk is also weak (1.8%), but more
significant than red. Based on these data, we choose to image sequentially, and thus
eliminate bleedthrough as a source of contamination because the laser and the channel are
always matched for this imaging sequence.
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Figure 21: Bleedthrough and crosstalk contamination by color. Excitation/emission
wavelengths (nm) are shown for each image. Red NPs (top row) have very little
contamination into other channels. Both types of contamination are less than 0.5%.
Green NPs (middle row) have more significant contamination, particularly as
bleedthrough. Ratio to matched fluorescence is shown (bottom table). Images are 2x2
μm2 and scaled equally.
From these data, we chose red as our NP to mark curvature since it has the least
crosstalk. This ensures we would not mistake lipid colocalization with NP locations.
Therefore green will be used to identify molecules of interest, and we possibly can
mistake molecule clusters for NP locations. This is unlikely due to the low crosstalk
percentage and relatively high red emission. Taking a ratio of average green crosstalk
fluorescence with average red matched fluorescence, the ratio is still only 1.9%. With
matched red fluorescence 50x brighter than the crosstalk from the brightest green object
possible, other green molecules of interest will not be mistaken for a NP. It should be
noted that this analysis can only ever be a proxy. Exact bleedthrough and crosstalk
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values are dependent on fluorophores used and the relevant microscope settings, most
importantly laser power and emission windows on the confocal. Given the low values
obtained, the similarity between proxy fluorophores and experimental fluorophores, and
similar microscope settings, we are confident this analysis of crosstalk and bleedthrough
is consistent for our experimental conditions. Therefore, our conditions will be as
follows: NPs are red (brightest), laser powers < 5%, small, nonoverlapping emission
windows, and sequential imaging to eliminate bleedthrough.
Controlling Chemical Composition
A primary goal of this biosensor is to be able to control the chemical composition
of the bilayer independent from the curvature. By mixing lipids in chloroform prior to
drying, different lipids are intermingled into a single bilayer and deposited after
resuspension. Initially, this was assumed, but Fӧrster resonance energy transfer (FRET)
verified our lipids were intermingling during preparation. FRET is a process where
energy is nonradiatively transferred from a donor molecule to an acceptor molecule.
Donor molecules have excitation/emission bands that are higher in energy than the
acceptor molecules. The emission band of the donor overlaps with the excitation band of
an appropriate acceptor molecule. This overlap permits nonradiative transfer if the
molecules are close enough (<10 nm) and the donor is in an excited state. Molecules
need to be extremely close, typically 3-5 nm for most efficient transfer. This has
interesting implications for FRAP. Prior to bleaching, little to no emission would be seen
in the donor channel. If the acceptor molecules are bleached, and thus unable to accept
the energy transfer, the donor emission would go up during the bleach frame. Subsequent
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frames would show a decrease in this donor emission. This technique is called
fluorescence loss after photobleaching (FLAP). If this fluorescence loss exists, then both
lipids are in the same bilayer.
To test our ability to mix and control the bilayer chemical composition, we tested
the addition of a second fluorescent lipid after a film of initial composition was created.
Bilayers were initially mixed and dried with 97.9% PC and 2% MB-DHPE (donor) via
chloroform evaporation, and then 0.1% Fl-HDA (acceptor) was added via DMSO and
sonicated in deposition buffer. Percentages are final molar percents. Our FRET studies
of this mixture are shown in Figure 22. When imaging these bilayers in the MB-DHPE
channel, nearly no fluorescence was seen. However, bleaching in the FL excitation band
at 488 nm caused a sudden increase in fluorescence in the MB emission channel. This
indicates that the molecules were experiencing FRET, but the destruction of acceptor
molecules by bleaching temporarily stopped the transfer.
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Figure 22: FLAP and FRET of mixed MB-DHPE and Fl-HDA bilayers. A) Loss and
recovery curves of MB-DHPE (blue) and Fl-HDA (green). Mobility is similar for
multiple extents of curvature. B) MB-DHPE (acceptor) fluorescence increases when
Fl-HDA (donor) molecules are bleached. C) Fl-HDA fluorescence is lost when
bleached. Scale bar is 3 μm.
To explore mixed mobility of lipids on curvature, we conducted an analysis of
variance (ANOVA) analysis of the FRET and FLAP data. This type of analysis would
indicate if the curvature had a different effect on diffusion when molecules are mixed as
opposed to being in a bilayer containing only one type of fluorescing lipid. Differences
when two types of lipid are present would arise if lipid domains form when one lipid is
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not miscible with the other domain. Diffusion would be hindered. An examination of the
diffusion constants when these lipids are solo in a PC bilayer versus mixed in a PC
bilayer was inconclusive. Table 2 summarizes the diffusion constants. An analysis using
a 2-Way ANOVA revealed MB-DHPE diffusion was unperturbed by the presence of
additional lipids, specifically Fl-HDA. We defined 2 sources of variation: one as a
change in curvature (flat, 40 nm, 100 nm), second as a change in mixing (mixed or not).
The interaction P-value for these variables was 0.7106, as expected for independent
variables. The high P-value indicates that the variance is very likely due to random
variation (71.1% chance). This indicates that the effect of mixing the lipids has the same
effect for MB-DHPE on any ROC. This insignificance permits further interpretation of
the two sources of variation. Neither curvature nor mixing had a significant impact on
diffusion constants (P-values > 0.40). Diffusion of MB-DHPE is neither perturbed by
curvature nor mixing. However, a similar analysis of Fl-HDA for these two variables
revealed inconclusive results. The interaction variable was significant (P-value =
0.0497), which does not permit interpretation of individual effects. This indicates that the
two variables for Fl-HDA are not independent and would imply that curvature affects the
mixing properties of the lipids, and thus the diffusion. As the ROC increases, diffusion
of the sensing molecule (Fl-HDA) is more hindered at lower ROC than it is when
diffusing alone for those same ROCs. This result is intriguing, but should be taken with
caution. The FRET data here has a low number of trials, and the recovery curve is only
fit to 17 frames. Both of these lead to very wide confidence intervals which decrease the
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likelihood of finding small variations, and fitting to a small number of frames can lead to
erroneous results entirely.
Table 2: Comparison of diffusion constants for two lipids. Analyzing by a 2-Way
ANOVA, MB-DHPE is unchanged by the presence of FRET. Fl-HDA is inconclusive as
indicated by the nonlinear changes in a mixed bilayer.
Diffusion Constants (μm2/s ± 95% Confidence)

MB-DHPE
(solo)
Fl-HDA
(solo)

Flat

40 nm

100 nm

n

Fit
Frames

3.70 ± 0.41

3.72 ± 0.47

3.73 ± 0.47

All = 15

37

2.57 ± 0.14

2.32 ± 0.09

2.09 ± 0.11

All = 5

37

MB-DHPE
(mixed)

3.57 ± 0.40

3.38 ± 0.34

3.41 ± 0.48

Fl-HDA
(mixed)

1.31 ± 0.16

1.18 ± 0.20

1.24 ± 0.24

Flat = 5
40 = 5
100 = 3
Flat = 4
40 = 5
100 = 3

17

17

To demonstrate that our biosensor is broadly useful, we incorporated lipids that
mimic the intracellular membrane. The intracellular leaflet of the plasma membrane in a
healthy cell is often markedly different than the extracellular leaflet. For example, in
endothelial cells, nearly all phosphatidylcholine and sphingomyelin lipids are on the outer
leaflet, while phosphatidylethanolamine and phosphatidylserine (PS) lipids are on the
inner leaflet (89). The early stages of apoptosis will cause PS lipids flipping to the outer
leaflet and be exposed to extracellular proteins (10). We were able to form stable
bilayers using 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) at relatively high
concentration. Table 3 details the diffusion constants and percent recoveries of bilayers
with increasing mole percent DOPS. MB-DHPE is kept constant at 2%, and soy-PC is
56

reduced proportionally (Ex: For 5% PS, there is 2% MB-DHPE and 93% soy-PC).
Recoveries were fit to 17 frames.
Table 3: Diffusion constants (<D>) and percent recoveries (<%R>) for bilayers formed
with DOPS.
Diffusion Constants (μm2/s ± 95% Confidence)
Percent Recoveries (% ± 95% Confidence)

5% PS - <D>
<%R>
10% PS - <D>
<%R>
20% PS - <D>
<%R>

Flat

40 nm

100 nm

n

4.62 ± 0.18

5.45 ± 0.20

5.62 ± 0.79

5

92 ± 2

88 ± 2

86 ± 1

5

5.16 ± 0.29

5.86 ± 0.60

5.80 ± 0.17

5

86 ± 2

94 ± 2

88 ± 1

5

5.72 ± 0.19

5.46 ± 0.25

6.26 ± 0.17

5

91 ± 1

93 ± 1

90 ± 1

5

We demonstrate that our biosensor forms fluid bilayers in the presence of relatively high
PS concentrations and that the negative charge does not interfere with bilayer fluidity or
formation. In future experiments, this will enable us to explore the effect of PS on
curvature sensing, which mimics aspects of early apoptosis. PS also has a strong
negative charge, which could cause significant changes to protein recruitment.
Conclusions from the Development of the Sensor
The first major contribution of this work is the development of the biosensor
itself. This tool consists of isolated nanoparticles covered in an SLB with defined
curvature independent from composition of the SLB. Use of this tool enables efficient
investigations into membrane curvature sensing. The current art of curvature sensing has
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some disadvantages, and this new biosensor overcomes many of these hindrances. We
demonstrate the dynamic equilibrium between lipids at a site of curvature and lipids on a
flat surface. The majority of our studies were done after one hour of incubation time.
Given the diffusion constants observed, this is long enough for the system to reach
equilibrium. Therefore, a binding molecule, whether lipid, protein, or anything else, can
bind anywhere on the continuum of lipids, then migrate to sites of ideal curvature. Good
spatial resolution is obtained from imaging individual NPs. Fluorescent NPs identify
sites of curvature, and easy alignment between fluorescent channels makes spatial
correlation between species of interest and curvature straightforward. In addition to the
studies in presented here, this is ideal for investigating single particle motion, which is
being pursued by other lab members.
Composition of the bilayer is controlled separately from the curvature of the
bilayer. We demonstrated surfaces patterned with one type and two types of NPs, but
this diversity can be scaled up to include a distribution of particles sizes. Using
fluorescence intensity as an indicator of size (66), a surface containing a range of particle
sizes can be examined as a continuous surface with a wide variety of curvature. The
inherent polydispersity from using silica nanoparticles would be ideal for use with this
biosensor. We mixed DOPS into soy-PC bilayers at varying mole fractions. This is
controlled during lipid film preparation and demonstrates our ability to control
composition independent of curvature control. Other lipids can be added via DMSO after
film formation.
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Analysis of the effect of mixing was only partly conclusive. For MB-DHPE, a
molecule that does not sense curvature, we conclude that the presence of mixing has no
impact on fluidity, with curvature or without. On the other hand, the observed diffusion
for a sensing molecule, Fl-HDA, does seem to show curvature affecting molecule mixing.
We speculate that the cause of this interaction term could be from the change in spatial
distribution of sensing molecules versus non-sensing molecules. Sensing molecules,
having an equilibrium favoring curvature, would outcompete non-sensing molecules at
those sites. Sensing molecules would displace non-sensing molecules causing an
exclusion of non-sensing molecules at sites of curvature, which would impact the
ensemble diffusion of both molecule types. Figure 23 schematically depicts this
speculation. This interaction would depend on the molecule’s sensitivity to the particular
ROC. More sensitive molecules would have large effects on mixed diffusion. We
recognize that this line of research needs to be explored more fully. Longer recovery
times for mixed bilayers need to be measured, and single-particle studies would help
illuminate any areas of exclusion that exist. Overall, our results show that FRET occurs
between MB-DHPE and Fl-HDA, and this indicates that lipids are within 10 nm of each
other on the supported bilayer.
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Figure 23: Potential mechanism for mixed bilayers. Sensing molecules, in orange,
equilibrate toward more curvature association. As these molecules redistribute (A to B),
they displace non-sensing molecules, in blue. This displacement would hinder diffusion
of sensing molecules, causing curvature to affect sensing molecules differently than nonsensing molecules.
Spatial dynamics are easily studied using this biosensor. Curvature is well
defined by the Gaussian fluorescence intensity distribution of the bright NPs, and
multiple channels of fluorescence permit many different species to be studied. Designed
with TIRF microscopy in mind, the biosensor has been used to address dynamics on two
levels, ensemble and single molecule. FRAP is well defined as a method to assess
mobility, and single particle tracking is an emerging technique able to study particle
motion in fine detail. Both levels are accessible using this biosensor. We foresee this
substrate as being highly useful when measuring transient interactions between lipids or
proteins and regions of membrane curvature.
A major disadvantage of this biosensor is that it is still hindered by the diffraction
limit. Resolution below ~300nm is impossible using direct imaging techniques.
Therefore, it is impossible to distinguish between binding to negative curvature at the
wings of a NP or the positive curvature on top of a NP. A way to overcome this
limitation is by using superresolution techniques (such as stochastic optical
reconstruction microscopy (STORM) (90)). Use of total internal reflection fluorescence
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microscopy on the biosensor gives a signal-to-noise ratio sufficiently high for these
techniques, and this is ongoing research in the lab.
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Chapter Four: Lipid Sorting
Before tackling the effect of curvature on proteins, we assessed the effect
curvature had on lipid partitioning for some known curvature sensitive and curvature
insensitive molecules. Using the ministack method we developed, we assess curvature
sensitivity by comparing lipid fluorescence at sites of curvature. Molecules that sense
curvature have increased fluorescence spatially coincident with nanoparticle locations;
those that do not will have uniform fluorescence across the field of view.
Lipids Partition to Curvature
We use DHPE-MB as a bilayer marker. While
curvature does not affect the rate of diffusion or percent
mobile fraction, it remains to be seen whether DHPEMB itself has curvature sensitivity. Using a mixture
with 98% soy-PC and 2% MB-DHPE, images were
taken of a fluid SLB over 100 nm NPs. Full images
were scanned at 12.5 μs/pixel. In Figure 24, ministack
analysis shows that at sites of curvature, DHPE-MB
does not have increased fluorescence and thus no
curvature sensitivity. The averaged image is nearly
uniform in intensity and a line scan across the center

Figure 24: DHPE-MB does not
sense curvature. Ministack
analysis of lipids (rightl) shows
no increase at 200 nm NP
locations (left). Line scan is
below. Red line indicates
scan. Image size is 2x2 μm2.

shows no noticeable increase. A line scan through the center of the image shows no
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increase at sites of curvature. This supports DHPE-MB as an appropriate choice as a
reporter for soy-PC fluidity.
Two other lipids have previously been shown to have curvature sensitivity, FlDHPE and Fl-HDA (3). When included in the SLB each at 2% by mole, deposited over
100 nm NPs, and imaged, both of these lipids were more abundant at sites of curvature
than in flat areas of the bilayer. Fl-DHPE and Fl-HDA both show colocalization with
regions of membrane curvature after a ministack analysis. Red fluorescent NPs (Figure
25a) are imaged followed by imaging of Fl-DHPE (Figure 25b) and an overlay reveals
that most NPs accumulate Fl-DHPE (Figure 25c). To quantify the ability of regions of
membrane curvature to bind lipids, a colocalization method was developed that involved
finding sites of curvature using an existing automated algorithm (81) then cropping a 25 x
25 pixel area around that region from both the green and red channels. If a green spot
appears in the center, an interaction exists between the two differently colors species. The
average cut out image for both lipids clearly reveals that Fl-DHPE and Fl-HDA prefer
sites of curvature (Figure 25d). The intensity can be quantified by plotting a line scan.
The normalized line scan conveys the enrichment of the green fluorescent lipids for sites
of curvature (Figure 25e). Fl-DHPE is more enriched than Fl-HDA, a single tailed lipid,
which is consistent with previous work (3). High lipid fluorescence not at sites of
curvature likely are lipids associating with non-fluorescing nanoparticles.
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Figure 25: Fluorescein labeled lipids accumulate in regions of curvature. A-C) Images
of the NPs (A) and Fl-DHPE (B) and an overlay (C) are shown. Images are 6.5x6.5
μm2. D) To quantify the colocalization, the red NPs are located using an automated
algorithm and a 2x2 µm2 region is cropped around each NP. The same region is
cropped out of the lipid images. An average of all cropped images shows the
accumulation of Fl-DHPE and Fl-HDA at regions of curvature. Additionally, a
randomized image of Fl-DHPE shows no accumulation. (C) A normalized cross section
of Fl-HDA, Fl-DHPE and a blank (containing no green fluorescent lipids) shows that
the accumulation is not bleedthrough. Fl-DHPE is more sensitive to curvature than FlHDA.
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As an additional negative control, we randomized the NP images for the data from
Fl-DHPE lipids. This scrambles any correlation the NP and lipid channels originally had.
If the increased fluorescence at NP locations is real and not an artifact of our ministack
method, scrambling the NP locations should give an even field of view in the final
averaged cutout. Using a plugin for ImageJ, JACoP (91), the NP image (Figure 26a) was
divided up into 4x4 squares and randomized. Figure 26b shows this new randomized
image with an overlay on the original image (Figure 26c). Both the original and
randomized images were used as a basis for determining NP locations for the ministack
procedure. The matrix of final, averaged images (Figure 26e-h) shows the results of this
analysis. The randomization has no effect on the average NP image, which is to be
expected. Since the NP image is used to find spots, it should resolve into a single spot
after image averaging. However, the average lipid images show a significant change.
After randomizing the NP image, there is no increase in lipid flouorescence at NP
locations (Figure 26h, also in 25d).
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Figure 26: As a negative control, randomizing the image eliminates accumulation
seen at sites of curvature. A-C) When overlaying an original NP image (A) with a
randomized counterpart (B), there is no colocalization in the overlay (C). D) Lipid
images remain unchanged. E-H) A matrix of Ministack analyses show a loss of
accumulation when the randomized image is used to determine NP locations. Image
size for A-D is 42x42 μm2, and E-H size is 2x2 μm2.
Labeling only one leaflet of the bilayer results in the same spatial distribution as
has been shown. Our current method to mix lipids together via sonication will disperse
fluorescent lipids to both leaflets of the SLB. Using a method originally developed for
cells (92), we asymmetrically labeled SLBs with Fl-HDA using fatty acid free bovine
serum albumin (BSA). By preloading BSA with Fl-HDA then incubating this BSA with
the SLB, this method inserts HDA into only the outer leaflet of the SLB after the SLB is
formed on the glass substrate. Transbilayer flip-flop is a concern, since flip-flop for fatty
acids is significantly faster than typical phospholipids (93). Uncharged hexadecanoic
acid flips with a half time of 3.5 s in egg-PC and cholesterol mixed GUVs. However,
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fluorescein is only fluorescent when charged, which causes a significant barrier to flipflop. Figure 27 show the results of these experiments. Increases for 200 nm NPs were
the most significant, with a 32.2% increase in fluorescence from baseline to the peak of
the line scan. This is similar to the increase shown in Figure 25e for Fl-HDA present in
both leaflets over 200 nm NPs. 100 nm and 40 nm also increased 11.6% and 1.7% at the
peak, respectively.

Figure 27: Asymmetric labeling of the lipid bilayer does not change curvature sensing.
A) An example overlay of the Fl-HDA channel and the nanoparticle channel shows
strong colocalization in the merged image. B) Ministack analysis of Fl-HDA. With
increasing ROC, the amount of colocalization increases. All images are 2x2 μm2 and
each channel is scaled the same. C) Line scans of the Fl-HDA ministacks quantify
sensing ability by plotting fluorescence intensity against position.
Recovery Directly over Nanoparticles is Slower than Flat Areas
Finally with regard to lipids, we have observed lipid recovery directly over NPs.
There was a concern that since the NPs are below the diffraction limit, recovery could be
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only surrounding the particles, and the lipids on top would not be mobile. Using images
from the Fl-DHPE experiments, lipids show recovered fluorescence at NP locations after
2 minutes of recovery time, instead of the usual 15 seconds. In panel A of Figure 28, an
example NP with associated recovery is shown. The increased fluorescence that is seen
before bleaching is also seen after bleaching. If these lipids were not mobile, they would
not be able to recover with unbleached lipids further away (> 2 μm). In panel B, the
slower recovery is seen in the plotted fluorescence against a longer time scale than seen
previously. Fitting to a single exponential, the observed diffusion constant for this
fluorescence directly over the sites of curvature was 0.64 ± 0.17 μm2/s (95% confidence
interval). The <R2> for this fit was 0.835 (n=5).
To elucidate the mechanism for this reduction in diffusion constant, we chose to
treat these data as containing two exponentials with respective k values, kl and kb, where
kl is the k value for the lipids, and kb is the k value for any additional bilayer properties
(Ex: defect sites or microdomains). The model these data were fit to is:

(Eqn. 11)

Ft, 0,  are fluorescence intensity values at a given time, initially, and equilibrium,
respectively. Pf is a partition term or the fractional contribution from the faster
exponential (kl), which makes 1 minus Pf the fraction contribution from the slower
exponential (kb). Therefore, we fit the same data as in Figure 28b to two exponentials,
but constrained one parameter, kl, to a constant value, 0.206 s-1, which corresponds to a
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Dl = 1.72 μm2/s. This value is the constant observed for Fl-DHPE on a flat bilayer.
Figure 29 shows recovery over flat glass side by side with recovery over a NP. With this
constraint, the new fit converged for 4 of 5 curves with an <R2> of 0.880 and the average

Figure 28: Lipids over NPs are in dynamic equilibrium with the surrounding
lipid pool. A) After bleaching, fluorescence recovers (left panels) at NP
locations (right panel). Scale bar is 1 μm. B) Directly over NP, fluorescence
intensity (<F>) recovers after bleaching at t=0s.
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kb for these fits was 0.036 s-1. Table 5 summarizes the parameters from this model and
other models. This is an improvement, but an analysis using an F-test is needed to
determine if this is a meaningful improvement in lieu of the change in model parameters.
When increasing the number of fit parameters to a data set, the goodness of fit will
increase and the degrees of freedom will decrease. The F-test will robustly account for
this decrease in degrees of freedom and allow a comparison between models. This test is
similar to the Student’s t-test as
it is a test of significance, and
the F-test becomes a
unidirectional t-test when only
one parameter is compared.
The observed diffusion constant
for kb was Db = 0.28 ± 0.20
μm2/s. The F-test analysis

Figure 29: Averaged recovery of lipids over flat sections
of bilayer compared to over curved sections of bilayer.
Recovery at sites of curvature is slower than over flat
would indicate that, if an
sections.
improvement is seen, the new effect is hindering recovery.
Using an F-test, we determined that this additional exponential term
improves the fit in a statistically significant way. Our null hypothesis was that the fit to
two exponentials shows no improvement over a fit to one exponential. Table 4
summarizes the calculations for determining the F-statistic, which was calculated to be
7.77. The null model (one exponential) had 34 degrees of freedom and the alternative
model (two exponentials) had 33 degrees of freedom. Using these values, the calculated
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P-value for this comparison was 0.0087, or a less than 1% chance that the improvement
in fit happened by random chance.

Table 4: Statistical calculations showing the improvement in fit from a 1-exponential fit
to a 2-exponential fit. This F-statistic corresponds to a P-value of 0.0087.

Improvement
(Difference)
2-Exponential Fit
(Alternative)
1-Exponential Fit
(Null)

Sum of
Squares

Degrees of
Freedom

Variance

F-Statistic

0.0777

1

0.0377

7.77

0.1601

33

0.00485

0.2378

34

In addition to the analysis above, we considered alternative analyses to support
our conclusion. 1) First, we used a 2-exponential model that had no constraints, and fit
this model to the data. Only 3 out of 5 curves converged on a best solution, but these
three had a good averaged R2 value of 0.877. Time constant parameters from this model
(Table 5) are in broad agreement with the parameters from the constrained model.
However, large confidence intervals, particularly for the partition term, Pf, make an
assessment of close agreement impossible. 2) Secondly, we assigned a model that
included three exponentials and added two parameters, a third time constant, k3, and a
second partition term, P2. This model failed to converge to a solution for any curve due
to the parameters being statistically interdependent. This result strongly implies that the
3-exponential model is overcomplicated for this data and that a 3rd exponential is not
present. To further confirm this conclusion, we assigned a model using four
exponentials. This also failed to converge on a solution. 3) Finally, we assigned a model
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using a distribution of exponentials and fit this to the curves. In this model, 100 evenly
spaced (on a log scale) time constants are selected. The upper and lower bounds are
calculated as the inverse of the largest and smallest observed spacing between time points
in the observation range of the recovery: lower bound from the time between two data
points, and the upper bound from the time between the first and last data points. Each of
the 100 exponentials has a partition term, Pi, and this partition term is varied until the
sum of the squares is minimized or the best fit is obtained. This method failed to
converge on a best solution due to the large number of fitting parameters. The model fits
100 variables while the recovery curve only has 37 data points. Even if a solution would
be found, this model would significantly overfit the data observed.
Table 5: Parameters to various models considered regarding fluorescence recovery over
single nanoparticles. Uncertainty is ±95% Confidence Intervals.

1-Exponential Fit
2-Exponential Fit
with kl constraint
2-Exponential Fit
without
constraint
3-Exponential Fit
Distribution of
Exponentials

kl (s-1)

kb (s-1)

k3 (s-1)

0.077±0.020

N/A

[0.21]
0.30±0.14

Pf

P2

N/A

N/A

N/A

0.028±0.024

N/A

0.51±0.17

N/A

0.018±0.016

N/A

.37±.52

N/A

This model did not converge on a best solution.
This model did not converge on a best solution.

Conclusions from Lipid Sorting
Our work has shown that bilayer curvature can provide a means for sorting lipids.
Curvature based sorting was tested on two fluorescein labeled lipids (Fl-DHPE and FlHDA) using the membrane curvature substrate designed and characterized here. On the
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substrate containing 100 nm diameter nanoparticles coated with a lipid bilayer, Fl-DHPE
binds with a higher density than Fl-HDA. This trend is observed in other work, where
liposomes (d ~ 100 nm) bind approximately twice the amount of Fl-DHPE compared to a
12 carbon fluorescein labeled fatty acid (3). Based on this previous work, the number of
carbons was proposed to be directly related to the density of lipids that bind to membrane
curvature, with longer chain lipids binding at higher density to regions of curvature. Our
work supports this by showing a slight increase in binding for Fl-DHPE, a lipid with two
16 carbon tails, relative to Fl-HDA, which has only one. We have also shown that this
sorting occurs when both leaflets are loaded with a sensing molecule or when only the
outer leaflet is loaded with a sensing molecule. These results also address potential
criticisms regarding the lipid directly interacting with the nanoparticle and affecting
spatial distribution. Loading the bilayer asymmetrically eliminates fluorescent lipid-NP
interactions.
Our data clarify a controversy between other research (5,3) and fills in a gap.
Theoretical work (5) indicates that lipid shape has a minimal effect on sorting into
curvature. In this work the curvature coupling constant, Γ, was measured for a series of
NBD labeled phospholipids. NBD-DHPE has a coupling constant of -2.13 nm, indicating
a preference for negative curvature. The following equation can be used to predict the
enrichment of lipids at on the outer leaflet of a liposome of curvature, H:
(Eqn. 12)
Where D is the thickness of a lipid bilayer and H is the curvature. H = 0.018 nm-1 and D
is 3.6 nm for PC bilayers, 49% of the DHPE lipids should be on the inner leaflet and 51%
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on the outer leaflet. More are on the outer leaflet merely because of the surface area
difference. If a lipid shows no curvature preference, this would be 47% and 53%,
respectively. Our observations show this difference to be much larger.
There are three possible reasons for our disagreement with this prediction. 1) The
shape of our substrate is not spherical. Within a diffraction limited area, the outer leaflet
contains both positive and negative regions of curvature. Our dye labeled lipid is added
during sonication and can be on either side leaflet. It is possible that Fl-DHPE binds to
regions of negative curvature on the inner leaflet as it curves around the top of the
nanoparticle and on the regions of negative curvature on the outer leaflet as the lipid
bilayer transitions from the nanoparticle to the flat supported lipid bilayer. Under the
fluorescence microscope this would appear as one spot, colocalized with a nanoparticle.
2) The fluorescein label is large relative to the NBD label, which could cause the
molecular shape of Fl-DHPE to be slightly different than that of NBD-DHPE, altering the
curvature preference of the lipid. Fluorescein is more hydrophilic, and due to the
difference in structure, we speculate has significantly larger hydrodynamic radius. Our
data do show a difference between DHPE when labeled with fluorescein versus marina
blue, indicating that fluorophore choice has an influence. However, NBD, MB and
Fluorescein head group labeled lipids are likely above the surface of the membrane, so
the mechanism remains unclear. 3) The concentration of Fl-DHPE (2%) is much higher
than previous work on NBD-DHPE (0.01%), which brings out different features in
curvature sensing. Recent work has suggested that cooperative lipid behavior can
facilitate curvature sensing (4).
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Given the symmetry to our sensor design, the first reason seems the most likely
explanation for our differences. This biosensor design neatly removes the theoretical
differences associated with differences in surface area. Since we see lipid increase at
sites of curvature, our data supports the presence of another mechanism separate from
differences in surface area. Defect sites only occur at sites of positive curvature, and are
a likely explanation to the differences observed in this work.
Curvature sensing lipids (Fl-HDA and Fl-DHPE) recover more quickly on flat
surfaces compared to these lipids directly over sites of curvature. Our analysis supports a
separate mechanism that is hindering lipid diffusion at sites of curvature that is not
individual lipid diffusion. We propose two potential mechanisms for this hindered
diffusion. First, defect sites (3) are consistent with these observations. Defects are areas
in the lipid membrane where head groups separate to reveal the hydrophobic tails.
Movement of these sites can be conceived as similar to movement of positively charged
holes in a doped semiconductor. If this comparison is valid, then defect sites would have
an independent diffusion constant that is hindered by the neck of the curved bilayer
where there is significant negative curvature.
Second, we consider that the extended recovery time is due to microdomain
formation at sites of curvature. This would limit the exchange from bleached
fluorophores on top of the particle and fresh fluorophores in the flat areas, thus
potentially causing the observed reduction in diffusion constant. Indeed, large ordered
domains do have diffusion constants on the order of what is calculated here (~0.1 μm2/s),
but these domains are 0.3 to 3.0 μm (94). Diffusion of domains is inversely proportional
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to radius. If microdomains are causing the effect seen in the current work, we predict the
size boundary to potentially range from 25 nm up to 300 nm (the diffraction limit).
Using the well known Saffman-Delbrück model (51), the calculated diffusion constant of
the domains range from 0.5386 μm2/s to 0.3263 μm2/s, respectively. This range is similar
to our observed Db, though the largest calculated microdomain is still faster than our
observation. This size is also very near the diffraction limit, meaning we would likely
see individually moving spots replace bleached fluorescence if this is the cause of our
observed Db.
In conclusion to this section, we have shown that lipids sort to different areas of
our biosensor according to the curvature of that bilayer. In congruence with previous
work, through using our novel ministack procedure, Fl-DHPE was more sensitive than
Fl-HDA to sensing curvature. We also have shown that recovery at sites of curvature is
hindered, and this hindrance could be another diffusing entity.
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Chapter Five: C-Reactive Protein Senses Curvature
Introduction of CRP
C-reactive protein (CRP) is a positive acute phase protein that participates in
activating the classical compliment immune response which, among many things, clears
damaged tissue and dying cells. It was first discovered by Tillett and Francis in 1930
(95), and is named because it precipitated C-polysaccharide derived from pneumococcal
cell walls. Phylogeny is highly conserved, and there is no known deficiency in humans.
It modulates complement activation in both apoptotic and necroctic cells (96,70).
Inflamed tissue can show a thousand-fold rise in CRP levels from basal levels (97),
which makes it risk factor for cardiovascular disease (CVD) and other inflammatory
diseases (98). There is growing evidence that CRP actively participates in vascular
events and is not simply a marker. In fact, CVD relevant studies of CRP include the
following: it has been shown to induce apoptosis in human endothelial cells (99), induce
production of pro-inflammatory cytokines (100), increase foam cell production (101),
increase phagocyte activity (96), destabilize plaque (102), and interestingly, stabilize
plaque (96). Other activities have also been identified (103). Isoform conversion has
been a subject of particular interest and has been proposed to be responsible for
conflicting observations of pro- and anti-inflammatory effects of CRP (104,105,106,107).
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The structure of CRP is well characterized by X-ray crystallography. Native CRP
is a homopentamer forming a pentagon with C5 symmetry. The crystal structure is
shown in Figure 30 (108). On one face of the pentagon are binding sites for calcium and
phophatidylcholine (PC). PC is one target for CRP and is found in all plasma membranes
in the body, though it does not bind ubiquitously. This binding is dependent on calcium
concentration, and the calcium site is near the PC site. The opposite face binds C1q
(109). CRP is approximately 10 nm across the face and 3 nm thick. Monomers are held
together noncovalently, and each monomer has C1 symmetry.
Isoform conversion has been implicated previously (97) as a mechanism for CRP
binding to endothelial cells. This work has shown the breaking up of native CRP (a
pentamer) into subunits, deemed mCRPm (a monomer or modified subunit that is
membrane bound). Subunit conversion occurred at monlayers and in liposomes of egg
PC/lyso PC, and at the plasma membrane of Jukart T cells. Conversion also occurs with
the disruption of the single, intra-subunit disulfide bond (110). This disruption retains
monomer activity, but prevents pentamer formation. Intrinsic tryptophan fluorescence
was shown to decrease in the presence of egg PC/lyso PC liposomes. This indicates the
loss of tertiary structure in pCRP as tryptophan residues were exposed to aqueous
solvent. Secondary structure was conserved, as demonstrated by circular dichroism
experiments (97). Using electron microscopy, the circular structure of pCRP was
observed converting to individual subunits over the course of 48 hours on egg PC/lyso
PC monolayers. Furthermore, the neoepitope expression ratio remained constant,
suggesting the membrane bound mCRPm retained the conformation of pCRP. After
78

detachment from the membrane, these mCRPm molecules showed antigenicity equivalent
to mCRP, and caused endothelial cells to generate interleukin-8 and chemokine ligand 2
more efficiently than pCRP. Interleukin-8 and chemokine ligand 2 are proteins that
induce an immune response targeted to the sites of protein generation. When reacted
with C1q, this membrane-bound conformer showed increased binding to C1q, suggesting
more efficient complement activation. This work indicates strongly that the plasma
membrane plays a significant role in CRP isoform conversion and CRP function.
Additional research (71) has investigated the interaction between mCRP and lipid
microdomains in endothelial cells. Using human aortic endothelial cells (HAECs),
researchers demonstrated an increased affinity to the cell surface and increased
internalization speed of mCRP over native CRP. mCRP also showed a factor of 20
increase in maximal protein binding to the cell surface over its native counterpart.
Binding was concentration dependent, saturable, and fit well to a single-site binding
model. Using egg-PC monolayers as a substitute lipid membrane, the researchers
observed an increase in surface pressure upon addition of mCRP, which indicates the
protein inserts into the monolayer. As further evidence, they showed colocalization
between fluorescein tagged mCRP with fluorescent markers that bind to lipid raft
microdomains both in the model eggPC system and in HAECs. The results of this study
indicate lipid rafts as viable binding domains for mCRP. Choloesterol is a possible
binding partner and CRP is thought to have two cholestrol binding domains (111). Taken
together, these studies reveal interesting new questions to be answered regarding CRP’s
interactions with apoptotic cells.
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Modified CRP shows a stronger link to pro-inflammatory effects than native
pCRP (105,112,113). Modified CRP is generated in vivo from pCRP at membrane
surfaces in activated platlets (112), apoptoic blebs (96), and oxidized low desnsity
lipoprotein (97,114). The antigenicity of the two isoforms of CRP are distinctly different
(115,116,117), and only modified CRP shows binding to C1q and compliment activation
in vivo (73). In addition to its chemokine production from endothelial cells (97), mCRP
can interact with neutrophils (104), platelets (118), and macrophages (119), cells that
play a key role in inflammatory responses. In neutrophils, mCRP was shown to
upregulate adehsion molecules, which results in increased adherance to endothelium
(113). Slowing of neutrophils in blood vessel flow and adhesion to blood vessel walls is
an early phase of inflammation (120). This process is mediated by a class of molecules
called cell adhesion molecules (120). Conversely, pCRP inhibits activation and
adherance of neutrophils (121). pCRP functions to inhibit neutrophil chemotaxis, though
some evidence indicates mCRP does this as well, using different receptors (106). mCRP
interaction with platlets caused an upregulation in P-selectin, another adhesion molecule,
which subsequently increases neutrophil aggregation (118). pCRP attenuates these
changes in platlets, and further inhibits platlet aggregation directly by inhibiting
phospholipases and reducing platelet aggregation caused by platelet aggregation factor
(122). One study suggested (123) that structurally modified CRP promotes the uptake of
LDL into macrophages. Macrophages are thought to become foam cells by taking up low
density lipoprotein (LDL) (106), a critical event in atherosclerosis. It is unclear however
if this structurally modified CRP is mCRP. A second study (124) demonstrated that
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native pCRP bound to LDL does not promote uptake. Taken together, these results
indicate that mCRP has a more pronounced pro-inflammatory effect than native pCRP.
However, as is seen with neutrophils, the role of CRP isoforms can be a complex topic.
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Figure 30: CRP crystal structure. In native form, CRP is a pentameric protein found in
the human bloodstream. It binds one phosphocholine head group (grey/red structure in
center of monomer) per monomer unit in a calcium dependent manner (Ca2+ is green,
two per monomer). Image was taken from the protein data bank (PDB Identifier: 1B09),
and the structure was solved in this work (108).
There are several ways that CRP could interact with the cell surface. Small
molecules and proteins have been identified as targets for CRP, such as PC headgroups,
low density lipoprotein (LDL), oxidized LDL, lysoPC, and FcγRIII (71). Although CRP
has a PC binding site, it will not bind PC on a flat bilayer. One study demonstrated CRP
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will bind to highly curved, PC coated gold nanoparticles (6). Here, CRP with Ca2+
present caused a shift in the localized surface plasmon resonance signal, indicating that
CRP directly modified the lipid structure surrounding the nanoparticle. There was a clear
cutoff in size, where CRP
bound to curved PC
membranes that were
presented on structures
smaller than 30 nm in
diameter. A consequence
of this study is that CRP
Figure 31: CRP curvature sensing is isoform specific.
Green spots are CRP; red spots are NPs. A) mCRP
will recognize a PC lipid
colocalizes with 100 nm particles. Yellow shows strong
colocalization. B) pCRP does not colocalize with curvature. membrane in the absence
Scale bar is 5 μm.
of other protein receptors or lipid oxidation when at regions of high curvature. This
result opens further questions regarding CRP since it confounds our understanding of
CRP’s specificity. Phosphocholine is a ubiquitous group found on the surface of all cells
in the body, not just apoptotic ones. Lipid rafts, often rich in PC lipids, are also not
specific to apoptotic cells. Some other mechanism other than presence of a ligand must
dictate specificity. These results imply CRP’s interaction could be related to the physical
structure of the binding site, a possible mechanism by which CRP interacts with the
curved blebs of apoptotic cells.
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Human C-Reactive Protein Isoform Recognizes Curvature
Given the implications of CRP binding curvature, the biosensor we developed
was an ideal method for determining if isoform changes would cause a change to CRP’s
curvature sensitivity. Upon treating CRP with 0.01% SDS and 70°C heat, CRP
monomerized. This treatment of CRP does not eliminate binding to C1q, the next protein
in the classical complement pathway, which indicates mCRP is still an active form (125).
mCRP preferentially bound to sites of curved bilayer whereas untreated pCRP bound to
flat areas of bilayer. A representative confocal image for mCRP is shown in Figure 31a.
In the overlay, areas of yellow show strong colocalization. In contrast, in Figure 31b,
confocal images for pCRP are shown. These have no observable overlap in the overlay

Figure 32: Comparison of ministacks of pCRP and mCRP at two extents of curvature.
A) Matrix of averaged ministacks for CRP isoforms, autoscaled. In both cases,
mCRP colocalizes to curvature, demonstrated by the increased intensity in the center
of the image. Because pCRP has reduced intensity in the center, this might indicate
curvature avoidance, but the high contrast makes these data inconclusive. The red
line indicates where the line scan was taken. B) Normalized fluorescence intensity
for line scans for the 4 ministacks. mCRP (in blue) increases 300-400% from the
background level. pCRP (in green) is flat relative to the background with a possible
dip in the center. Images are 1x1 μm2.
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image. A comparison of ministack images in Figure 32 shows that even under this
sensitive technique, no pCRP intensity is seen at locations of curvature. Line scans of the
mCRP data show a 300-400% increase in intensity at locations of curvature. Averaged
images of pCRP potentially show avoidance of the curved regions (Figure 32a), but the
change is extremely small once normalized to the overall image intensity. Other methods
were explored to evaluate colocalization, but these methods were found insufficient for a
variety of reasons. In particular, an intriguing thresholding method (80) showed promise
initially. Briefly, this method assesses colocalization by comparing the pixel intensity of
two channels in a scattergram. It incrementally decreases a threshold for each channel
until the Pearson coefficient of the pixels below the thresholds is 0. Then pixels above
the threshold are considered colocalized. Unfortunately, this method ultimately proved
too sensitive to background noise. This is because individual pixels were examined, not
features. Due to the high sensitivity required to image CRP on the surface, pixel intensity
for the background was sufficient enough to be considered correlated in this method.
Single Particle Tracking
Finally, we investigated the mobility of CRP at the single particle level using
TIRF microscopy. Confocal microscopy revealed the preference of curvature at the bulk
level, but recent work has shown that ensemble and single particle measurements do not
necessarily align (4). Both m- and pCRP have a mixture of mobile and stationary
particles on the surface of the biosensor. Figure 33 shows a typical track of mCRP. Full
movies of trackable particles can be obtained in TIRF, and these data could elucidate
transient interactions with curvature. However, several areas of troubleshooting remain
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to be explored. These data are encouraging by showing
proof of concept for single molecule tracking using the
biosensor, and this line of research is being pursued by
other members of the Knowles group.
Characterization of Human C-Reactive Protein
There are at least two distinct isoforms of CRP, and
we have begun studying the different structures that arise as
CRP unfolds. In Figure 34, native pCRP is denatured using Figure 34:
Representative track of
two separate methods, and the absolute tryptophan
pCRP moving on the
surface of an SLB.
fluorescence measured. Using a plate reader, we examined
the fluorescence from the amino acid tryptophan. This fluorescence is very sensitive to
solvent environment changes, and fluorescence reduces when moving from a
hydrophobic environment to a hydrophilic environment. CRP has 30 tryptophan

Figure 33: Two separate methods of denaturing CRP indicate a stable isoform exists
between the native form and a fully denatured state.
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residues, and is a good candidate for a tryptophan fluorescence assay. With increasing
concentration of guanidine hydrochloride or after 45 minutes, there is a distinct central
plateau in fluorescence indicating a stable transitional state. This central isoform does
still bind to C1q (69), and is thought to be the active, modified form of CRP (mCRP).
Equimolar free tryptophan has a normalized fluorescence of approximately 50%.
CRP was detected through primary and secondary antibody binding. We initially
considered directly labeling CRP with a dye, but this process caused CRP to misfold to
an unidentified, broad band on native gel. Therefore we
selected an antibody pair to visualize CRP. Primary
mouse anti-CRP was purchased from Santa Cruz
Biotechnology and secondary goat anti-mouse
immunoglobulin G with Alexa-488 was purchased from
Life Technologies. Several primary antibodies were
tested with varying success. The final candidate, clone 8
(C8) from Santa Cruz, was the most consistent. Dot blots
(Appendix B) can be used to determine if an antibody (or

Figure 35: Dot blot of
CRP shows the antibody
pair selected binds to
CRP.

pair) will successfully bind to a specific protein. This is a qualitative assay where the
protein is known. An example dot blot in Figure 35 shows that this antibody pair we
used does bind sufficiently to CRP. The center spot is where CRP was dotted onto
nitrocellulose, and after treatment with two antibodies (primary C8 and secondary),
fluorescence is seen at the protein spot.
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Figure 36: SLB prevents adherence and binding of non-membrane binding entities.
Without an SLB, secondary antibodies bind to bare glass (A). With an SLB, neither
primary/secondary antibodies (B) or primary/secondary antibodies with BSA (C) will
significantly bind to the surface. Contrast is scaled the same for all images.
Without the presence of CRP, the antibody pair does not bind to the surface of the
biosensor. Figure 36 shows confocal images of the antibodies without a bilayer present,
with a bilayer, and with a bilayer and BSA. Without a bilayer present, antibodies stick to
the surface of the glass. With a bilayer or with BSA present, no fluorescence is seen in
the protein channel indicating no binding. Therefore in the presence of CRP, we know
that when fluorescence is seen at the bilayer surface, it is due to CRP binding, not
antibodies only.
Aptamer Specific to mCRP
While antibodies are an excellent method for visualizing CRP when the isoform is
known, a tool is needed to identify the isoform when it is not known. CRP is notorious
for displaying contradictory inflammatory effects, and this is attributed to the difficulty in
identifying which isoform is at work (106). In collaboration with researchers at the
University of Colorado – Denver (69), we identified an RNA aptamer that specifically
binds to mCRP and not pCRP. The aptamer (Integrated DNA Technologies, Inc) was
end-labeled with either Cy3 on the 5’ end (5’Cy3-RNA) or Cy5 on the 3’ end (3’Cy588

RNA) and stocks of aptamers were reconstituted with diethylpyrocarbonate (DEPC)
treated water to remove nucleases and stored at -20°C until use. The sequence for the
RNA aptamer used in this study is as follows: 5’-GCC UGU AAG GUG GUC GGU
GUG GCG AGU GUG UUA GGA GAG AUU GC-3’.

Figure 37: RNA aptamer will selectively bind to mCRP. A) Control image with no
CRP present. B) mCRP is captured on the surface with a nonspecific antibody and
aptamer is present. C) pCRP is similarly captured in the presence of aptamer. D)
Comparison of integrated fluorescent intensity shows increased aptamer binding to
mCRP compared to pCRP or the control. Data is mean ± SEM. Using Student’s t-test,
**P-value <0.01 and #P-value <0.05. Comparison of pCRP to the control showed
similar integrated intensities (P-value > 0.20). Scale bar is 40 μm.
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Binding between 5’Cy 3-RNA and surface-bound CRP was analyzed using TIRF
microscopy. TIRF permits the selective excitation of 5’Cy3-RNA attached to the surface
while excluding 5’Cy3-RNA in the bulk solution. Therefore, binding events can be
detected with low background noise by comparing the intensity and distribution of
fluorescence spots on the surface. Integrated fluorescence intensities (F) of each sample
were subjected to image processing and plotted (Figure 37). Anti-CRP antibodies were
used as a capture method to avoid pCRP conversion associated with direct capture. The
integrated intensity of the 5’Cy3-RNA control on the anti-CRP antibody coated coverslip
was 18.8 ± 0.51 (×106). A significant increase in intensity was measured (ΔF = 3.2×106,
P-value < 0.01, Student’s t-test) when mCRP-5’Cy3-RNA was added to the antibodycoated coverslip as evident from the increase in spot density on the surface (Figure 37b).
In contrast, addition of pCRP-5’Cy3-RNA (Figure 37c) caused a slight decrease in
fluorescence intensity (ΔF = 1.1×106, P-value > 0.2, Student’s t-test), and the spot density
on the surface was comparable to the 5’Cy3-RNA control (Figure 37a), demonstrating
that 5’Cy3-RNA binds to mCRP but not pCRP.
The specificity of the aptamer for mCRP was also supported by anisotropy and
gel electrophoresis work done by our collaborators at the University of Colorado at
Denver (69). We demonstrated that an aptamer previously isolated against CRP (126)
has a strong affinity for the mCRP isoform and does not associate with pCRP under the
same conditions. A solution binding analysis using fluorescence anisotropy was used to
identify which isoforms of CRP bind to the aptamer, 5′Cy3-RNA (Figure 38).
Fluorescence anisotropy measures the change in rotational diffusion rate of a fluorescent
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probe and has been used to measure the interactions of biomolecules (127,6,128).
Labeled aptamer should freely rotate and have a lower anisotropy than if it is bound to
CRP. Addition of mCRP (labeled mCRP-SDS in Figure 38 and mCRPSDS for the rest of
this section for clarity between this and mCRPHCl) to the 5′Cy3-RNA aptamer resulted in
a significant increase in anisotropy (Table 6), with a Δr of +0.097±0.019. This is
compared to a CRP denaturing method that eliminates the ability to activate compliment,
mCRPHCl (129). Addition of mCRPHCl to the 5′Cy3-RNA aptamer also resulted in a
significant increase in anisotropy (Table 6), with a Δr of +0.107±0.016. In contrast, when
the same amount of pCRP was added to the 5′Cy3-RNA aptamer the Δr was +0.014 ±
0.007 showing that the much larger pCRP had negligible affinity for the aptamer. The
final concentrations of 5′Cy3-RNA and CRP were 0.59 and 9.1 μg/mL, respectively. In
an additional control, no binding was observed between the aptamer and BSA (Figure 38)
confirming that the interactions observed were specific.
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Figure 38: Solution binding analyses between 5’Cy3-RNA, CRP, and C1q using
fluorescence anisotropy. Baseline anisotropy readings of 5’Cy3-RNA (0.59 μg/mL) were
acquired prior to the addition of (green) mCRPSDS, (red) mCRPHCl, (yellow) pCRP or
(blue) BSA (each at 9.1 μg/mL) at the first indicated time point. At the second indicated
time point, an aliquot of C1q (5.8 μg/mL) was added to the CRP-aptamer complex and
evaluated for complement activity.
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Table 6: Degree of binding between 5’Cy3-RNA and CRP (Δr1) and between CRP and
C1q (Δr2) determined by the change in anisotropy. n=3, *P<0.001 compared to BSA
control.
Sample

Δr1 (Mean ± SD)

Δr1 (Mean ± SD)

mCRPSDS

0.097* ± 0.019

0.099* ± 0.015

mCRPHCl

0.107* ± 0.016

0.013 ± 0.009

pCRP

0.014 ± 0.007

0.013 ± 0.008

BSA

0.018 ± 0.005

0.009 ± 0.005

Although the RNA aptamer recognizes both forms of mCRP, the bioactivity of
each mCRP form was noticeably different. Since modified CRP has been shown to
activate complement in vivo (79), binding studies between mCRP and C1q were further
evaluated by anisotropy to assess the biological activity of the each mCRP (Figure 38).
The mCRPSDS isoform bound to C1q, resulting in a significant increase in anisotropy,
with a Δr of +0.099±0.016 in the presence of 0.01% SDS (Figure 38). This confirms that
mCRPSDS is functional even though it is not in the pentameric form. In contrast,
mCRPHCl did not interact with C1q (Δr = +0.013 ± 0.009) (Figure 38) and adding the
same concentration of SDS to mCRPHCl did not restore C1q binding, consistent with acid
treatment resulting in complete and irreversible denaturation. The final concentration of
C1q in each case was 0.58 μg/mL. In addition, ELISA confirmed that mCRPSDS bound
C1q better than either pCRP or mCRPHCl (Figure 39). The binding between C1q and
mCRPSDS was twice as strong compared with that of the mCRPHCl by ELISA. As
expected, no binding was observed between pCRP and C1q by ELISA. The strong
binding between C1q and mCRPSDS suggests that CRP heated in a minimal amount of
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SDS is likely to retain a folded structure as do other proteins at low SDS concentration
(130). On the other hand, the acid treatment (mCRPHCl) rendered the CRP irreversibly
denatured (116,129) and without the ability to activate complement, which is in
agreement with previous observations (129). These results demonstrate that the
mCRPSDS remains biologically active and expresses the neo-epitopes responsible for C1q
binding which occurs through the Asp 112, Tyr 175, and His 38 residues on CRP (109).
This also suggests that the aptamer specifically recognizes a portion of CRP that is

Figure 39: Binding of different CRP isoforms to immobilized C1q. ELISA wells were
coated with C1q (1μg/mL) and incubated with various modifications of CRP at
increasing concentrations. The degree of CRP binding was detected using biotinylated
polyclonal anti-CRP antibody (1:5000) with a streptavidin-HRP conjugate (1:10,000)
and the absorbance of TMB substrate was measured on a plate reader at 450 nm with
background subtraction at 620 nm. mCRPSDS was formed by heating with 0.1% SDS.
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blocked when protomers are adjacent to each other, and that the mCRPSDS shows similar
antigenicity to the modified CRP found in tissues and human arterial intima (73,131) that
are relevant to biological function in complement activation. Because of its high affinity
to C1q, we consider the mCRPSDS as similar to the biologically relevant form of modified
CRP. Although both mCRPSDS and biologically modified CRP bind to C1q, additional
study will be required to fully understand the antigenicity of mCRPSDS. Since mCRPSDS
appears to be a better model of modified CRP than does mCRPHCl, and because modified
CRP and mCRPSDS both have an intact C1q binding site (97), we therefore sought to
further characterize the interactions of the aptamer probe with mCRPSDS.
To provide direct visual evidence of the protein–aptamer complex, we performed
a dot blot assay and adapted standard PAGE methods for electrophoretic mobility shift
assay (EMSA) to create an in-gel assay using a 3′Cy5-RNA and NIR imaging. The
5’biotin-RNA showed strong affinity for mCRP, with relatively weak binding to pCRP,
and no affinity for BSA (Figure 40a). To further observe the specificity of aptamer for
mCRPSDS over pCRP, the proteins were separated by PAGE and visualized using silver
stain (Figure 40b) and near infrared (NIR) imaging (Figure 40c). When resolved on a
10% polyacrylamide gel containing 0.005% SDS, pCRP showed an apparent MW of 140
kDa and mCRPSDS had an apparent MW of 48 kDa (Figure 40b). This high MW is
caused by the nearly native conditions used and is in agreement with a previous study
using the same gel conditions (132). NIR imaging of the same gel revealed a distinct
band at 48 kDa in the mCRPSDS and 3′Cy5-RNA co-incubated sample (Figure 40c). This
suggests that mCRPSDS forms a complex with 3′Cy5-RNA that has a similar mobility to
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the protein alone. In contrast, no additional bands were observed in the pCRP + 3′Cy5RNA lane (Figure 40c), indicating that 3’Cy5-RNA did not form a persistent complex
with pCRP. To further evaluate the complex formation of mCRPSDS-3’Cy5-RNA, EMSA
was performed using increasing concentrations of 3′Cy5-RNA into a fixed amount of
mCRPSDS and resolved on a 5% 0.5× TBE acrylamide gel (Figure 41). NIR EMSA gel
showed increasing mCRPSDS-3′Cy5-RNA complex formation with increasing 3′Cy5RNA concentration and a difference in mobilities of the free 3′Cy5-RNA and the
mCRPSDS-3′ Cy5-RNA complex bands (Figure 41a), confirming the formation of an
mCRPSDS-3′Cy5-RNA complex. Silver staining of the same gel also confirmed that the
mCRPSDS-3′Cy5-RNA complex migrated differently than free mCRPSDS (Figure 41b),
and the mCRPSDS-3′ Cy5-RNA complex bands from both techniques overlapped with the
3′Cy5-RNA bands observed by NIR imaging (Figure 41c). In contrast, migration of
pCRP did not change in the presence of 3′Cy5-RNA and no complex was observed
between pCRP and 3′Cy5-RNA. Both dot blot and EMSA results clearly showed that 3′
Cy5-RNA interacts only with mCRPSDS and not pCRP, as indicated by a distinct
mCRPSDS-3′Cy5-RNA complex band, visible by NIR imaging (Figure 41b). The main
advantage of this adapted EMSA method is that both the protein and protein–aptamer
complex bands can be resolved on the same gel without the need to perform a Northern
blot or the use of radioisotopes.

96

Figure 40: CRP-RNA complex formation. A) Dot blot assay was carried out by blotting
CRP and BSA onto nitrocellulose and detected using a biotinylated aptamer (177nM)
followed by streptavidin conjugated-IR 800 (1:1000) and imaged on an Odyssey NIR
imager. CRP was preincubated with 3’Cy5-RNA before resolved on a 10%
polyacrylamide gel containing 0.005% SDS. Protein bands were visualized by B) silver
staining and the gel was imaged for 3’Cy5-RNA and CRP-3’Cy5-RNA complex using C)
NIR imaging.
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Figure 41: EMSA of mCRP and pCRP using 3’Cy5-RNA probe. A) In-gel visualization of
3’Cy5-RNA and 3’Cy5-RNA-mCRP complex using NIR imaging, and B) visualization of
CRP bands by silver staining of the same gel. C) Superimposed image of the NIR image
and silver stain gel, highlighting the overlapping areas of the 3’Cy5-RNA-mCRP
complex.
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Increasing concentrations of mCRPSDS were added to 5′ Cy3-RNA to obtain a
binding constant for RNA aptamer and mCRPSDS using anisotropy (Figure 42a). The
starting concentration of 5′Cy3-RNA was 0.68 μg/mL and aliquots of mCRPSDS were
titrated into the solution. The titration curve showed a saturation binding equilibrium
between 5′ Cy3-RNA and mCRPSDS, starting with an initial anisotropy value of
0.299±0.009 for the 5′Cy3-RNA probe, followed by a gradual increase in anisotropy, and
finally reaching a maximum anisotropy of 0.381±0.007. The data were fit using
nonlinear least squares regression (GraphPad Prism 5). From the fit curve, the CRP
concentration at half-maximum was 4.34 μg/mL. This corresponds to a Kd of 187.7 nM
(using the MW for mCRP of 23 kDa), comparable to that of the previously reported Kd
for this aptamer (133).

Figure 42: Quantitative binding studies between RNA-aptamer and mCRPSDS. A)
Saturation binding curve of 5’Cy3-RNA aptamer (0.68 μg/mL) with increasing mCRPSDS
concentrations. B) Competitive displacement assay with increasing concentration of
ssDNA. Titrations of ssDNA were added to a solution containing mCRPSDS-5’Cy3-RNA
complex (18 μg/mL mCRPSDS and 0.68 μg/mL 5’Cy3-RNA) Data represents mean ± SE,
n=3.
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In addition to the RNA aptamer, a second aptamer against CRP has been recently
selected (79). Because the ssDNA aptamer was selected against CRP bound to magnetic
beads (79), we expected the ssDNA aptamer could also be mCRP specific and possibly
compete for the same binding site as the RNA aptamer. To determine if the DNA
aptamer also binds mCRP, we performed a competitive displacement study using the
CRP-specific ssDNA aptamer as a competitor (Figure 42b). Increasing amounts of
ssDNA aptamer were added to the mCRPSDS-5′Cy3-RNA complex until the anisotropy
reached the baseline value. The initial concentrations of the mCRPSDS and 5′Cy3-RNA
were 18 μg/mL and 0.68 μg/mL, respectively. The initial anisotropy of the mCRPSDS5′Cy3-RNA complex was 0.381±0.006 (the maximum anisotropy value) and no
significant changes in anisotropy were detected at lower titrations of ssDNA. After an
initial lag phase, a decrease in anisotropy was observed and the drop in anisotropy
proceeded to a plateau at a final minimum anisotropy of 0.288±0.01. The competitive
displacement data were fit to a dose-dependent Hill equation and the concentration of
ssDNA needed to displace 50% of the 5′Cy3-RNA from the mCRPSDS-5′Cy3-RNA
complex (EC50) was 0.83 μg/mL (GraphPad Prism). A complete displacement of the
5′Cy3-RNA was achieved at ssDNA concentrations greater than 1.6 μg/mL, or
approximately 2X molar excess of the 5′Cy3-RNA. In an inhibition assay, when ssDNA
aptamer was added to mCRPSDS prior to the 5′Cy3 RNA aptamer addition, no change in
anisotropy was observed (data not shown). This competitive displacement assay
suggested that the ssDNA has strong affinity to mCRPSDS, suggesting that both aptamers
may bind to the same epitope on the mCRPSDS consistent with the ssDNA also being
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specific to mCRP. This further highlights a general problem with using SELEX to obtain
aptamers for proteins that are prone to aggregation or conformational changes. The bulk
of the work done in this section was done with Dr. Min Wang.
Conclusions on CRP Sorting
The discussion about CRP isoforms has remained an active topic for the past
decade (105,104,106,107). Using a variety of methods to denature CRP, our data further
confirm that (at least) a three state model for denaturing is appropriate (Figure 34).
CRP’s ability to bind to C1q after denaturing to this second state, but not binding in the
native state, implies that it is this non-native isoform that is functional at the surface of a
cell.
The difference in curvature sensitivity between isoforms also has implications to
the active form at the cell surface. As an indicator for apoptotic cell removal, CRP must
be able to distinguish between healthy and apoptotic cells. A defining characteristic of
apoptotic cells is the physical change to the plasma membrane, notably the changes to
extents of curvature. Our data indicate that the change in CRP to this second, C1qbinding isoform will bind to a soy-PC bilayer and recognize curvature. Interestingly,
CRP will bind to the membrane as a native, pentameric form, but either has no preference
or weakly avoids curvature. After conversion, CRP strongly binds to curvature. This
suggests that small scale curvature, where radii are less than 100 nm, plays a major role
how CRP differentiates between healthy and apoptotic cells. Other work indicates that
pCRP will bind curvature only below ROC of 30 nm (125).
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Finally, we identified an aptamer that will successfully differentiate between
mCRP and pCRP. By using this aptamer, isoforms can be distinguished in a variety of
situations. Our biosensor is one such opportunity, but this aptamer could be used in
cellular studies as well. Some studies (134) indicate that CRP could change isoform at
the surface of cells. This aptamer would be ideal to investigate these changes.
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Chapter Six: Summary
This work has outlined the development of a biosensor able to investigate the
curvature sensing properties of lipids and proteins. The biosensor consists of
nanoparticles noncovalently adhered to a glass surface with a supported lipid bilayer
formed over them. This induces curvature in the bilayer independent of bilayer
composition. Using fluorescence microscopy, the amount of sensing can be assessed
through colocalization with nanoparticles and FRAP. This unique approach has several
advantages over other methods currently in use. 1) Most notably, our sensor allows
lipids at sites of curvature to be in dynamic and ready equilibrium with lipids not at
curvature. 2) This permits us to make conclusions based on a mimic that models large,
flat membranes. This is ideal for modeling the plasma membrane or large organelles. 3)
Our sensor also offers significant control over the composition of the bilayer that is
independent from the induced curvature. This permits targeted investigations that could
help unravel the interplay between curvature and lipid sorting. 4) The heterogeneity of
this setup allows specific sorting to ROC after initial binding to the bilayer. 5) The
preparation is simple and quick. 6) And finally, the sensitivity of this assay is high
enough to permit single-molecule studies. This sensitivity is crucial to being able to
probe kinetic effects such as cooperativity and nonergodic systems. Rare, transient
interactions between biomolecules could be observed.
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Curvature influences lipid and protein interactions with bilayers. We have shown
that lipids partition differently in the presence of curvature and that these lipids do
exchange with lipids in flat regions, though more slowly. This supports other work
indicating the presence of defect sites at areas of curvature, and we propose that these
defect sites have an influence on lipid diffusion. We have also shown that curvature will
influence the isoform-dependent binding of CRP. Pentameric CRP will bind to
phosphocholine bilayers, but will not bind to curvature sites. Monomeric (or modified)
CRP will bind preferentially to sites of curvature. This implies a mechanism for CRP
recognition of apoptotic cells instead of healthy cells.
Future Work
Several opportunities exist to pursue work using this biosensor. Currently, work
is being done to investigate the dynamics of single lipids and to discern any cooperative
effects that result. We speculate, with others (4), that cooperative effects cause
differences between single particle motion and ensemble motion. Single particle studies
could also illuminate any corralling effects that curvature could impart on lipid motion.
Further investigations into mixtures of lipids, via FRET, FLAP, and FRAP, would
provide insight into how compositions of lipids change the fluid parameters. Phase
transitions have an effect on lipid sorting (59), which has implications for micodomain
activity, vesicle trafficking, and other membrane deforming processes.
CRP recognition of apoptotic cells is being further explored by other group
members. Isoform conversion could have significant impacts not just on membrane
sorting, but also on activation of other proteins. One candidate is C1q. This is another
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complement protein and known binding partner to CRP. It is the next protein in the
pathway to complement activation. C1q’s binding to the biosensor could be explored in
the presence of either isoform of CRP. C1q can bind to either PS or CRP, and it would
be interesting to explore the curvature recognition of this protein in the presence of
various binding partners.
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Appendix A: Acronyms
AFM – Atomic force microscopy
ANOVA – Analysis of variance
BAR – Bin-Amphilphysin-Rys
CRP – C-reactive protein
CVD – Cardiovascular disease
DEPC – Diethylpyrocarbonate
DMSO – Dimethyl sulfoxide
DOPS - 1,2-dioleoyl-sn-glycero-3-phospho-L-serine
Fl -HDA – Fluorescien hexadeacanoic acid
FLAP – Fluorescence loss after photobleaching
Fl-DHPE – Fluorescien 1,2-Dihexadecanoyl-sn-Glycero-3-Phosphoethanolamine
FRAP – Fluorescence recovery after photobleaching
FRET – Föster resonance energy transfer
GUV – Giant unilamillar vesicles
HAEC – Human aortic endothelial cells
MB-DHPE – Marina Blue 1,2-Dihexadecanoyl-sn-Glycero-3-Phosphoethanolamine
mCRP – Monomeric CRP or modified CRP
MWCO – Molecular weight cutoff
NBD - [2-(4-nitro-2,1,3-benzoxadiazol-7-yl)aminoethyl]trimethylammonium
NP – Nanoparticle
PAGE – Polyacrylamide gel electrophoresis
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PC – Phosphocholine
pCRP – Pentameric CRP or native CRP
ROC – Radius of curvature
SDS – Sodium dodecyl sulfate
SLB – Supported lipid bilayer
SLiC – Single liposome curvature
STORM - Stochastic optical reconstruction microscopy
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Appendix B: Protocols
Dot Blot Protocol
Buffer:
TTBS: 50 mM Tris, 0.5 mM NaCl, 0.05% Tween-20, pH 7.4
Protocol:
1.

Cut a piece of nitrocellulose into a circle that will fit into the smallest cell
culture dish

2.

Dot onto the nitrocellulose an appropriate concentration. Use
approximately 10 uL. You can blot various concentrations to gauge
what’s needed for a Western. A suggested concentration is less than 50
nM.

3.

Incubate on the membrane at room temperature until the blots are dry.
This is about an hour.

4.

Block the membrane with 5% dry milk in TTBS for 1 hour. Pour off the
buffer. Keep the membrane wet for the remainder of the procedure.

5.

Incubate in primary antibody for 1 hour at 1:5000 dilution at RT in TTBS.

6.

Wash the membrane 3 times (10 minutes each) in TTBS on a rocker.

7.

Incubate in secondary antibody for 1 hour at 1:5000 dilution at RT in
TTBS.

8.

Wash the membrane 3 times (10 minutes each) in TTBS on a rocker.

9.

Image.
TIRF Startup Protocol
Startup

1. Turn on power strip behind the laser system.
2.

Wait for 2 lights to be lit steadily (no blinking) on each laser power
supply. These should be “Power” and “Temp Lock.”

3.

Turn on both keys if using both lasers.
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4.

Turn on the computer.

5.

Run the Micromanager program. Hit ok to load configuration.

6.

Wait for the camera to cool down to -70˚C. This should take 3-4 minutes.
This can be monitored from the Device/Property Manager under the Tools
menu.

7.

Once camera is cooled, the system is ready for imaging.

8.

The TIRF field is controlled by the knob on the front side of the black
launch behind the microscope. This adjusts the angle of the laser and, in
turn, the TIRF field. Clockwise increases laser angle of incidence;
counterclockwise decreases laser angle.
Other Comments



The objective is an oil objective. One drop of oil is good for 3-5
coverslips. To clean, use ThorLabs lens paper with isopropenol. NOT
KIMWIPES.



Close the shutter on the camera (controlled from Micromanager) if the
overhead lights are turned on for lengthy periods (more than a minute).



Do not use EM Gains above 300 if it can be avoided. Most standard
imaging (exposure times of 100ms+) do not need large EM Gains.



DO NOT SATURATE THE CAMERA. This can quickly destroy the
camera. If it is saturated, reduce EM Gain and exposure time.



If there is a problem, contact Michelle in Mudd 101 (Phone:1-6698, 503267-2430), or Josh or Phillip in Mudd 259 (Phone: 1-2984)
Shutdown Protocol

1. Shut down Micromanager.
2.

Turn off both keys on the laser power supplies.

3.

Wait for 2 steady lights (no blinking). These should be “Power” and
“Temp Lock.”

4.

Turn off the power strip behind the laser system.

Turn off the computer.
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